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Abstract

(Part I.) The purpose of this study was to measure insulin regulated glucose
transport and GLUT4 protein in aortic tissue from insulin-resistant vs. sensitive rats.
We assessed basal and insulin-stimulated [3H]-2-deoxyglucose transport in aorta from
lean vs. obese Zucker rats. In a muscle-bath system, insulin significantly stimulated
aortic 2-deoxyglucose transport by 30% in lean and obese animals. Further, in the
perfusion system with only the luminal vessel exposed, insulin significantly stimulated
2-deoxyglucose transport in aorta of lean animals.

Western blot analysis

demonstrated that aorta contained substantial concentrations of GLUT4 protein.
These data demonstrate that the aorta is insulin-sensitive and partially impaired in
the insulin resistant animals. (Part II.) The purpose of this study was to determine
if there is a fa allele effect in BN/fa rats subjected to a high fat diet. BN/BN and
BN/fa male/female rats were fed 12% or 48% fat diets for 7 weeks. Food intake
and weight change were recorded weekly to obtain an index of energy efficiency ratio
(BER) and blood and tissue were harvested for subsequent analysis. Plasma insulin,
glucose and cholesterol concentrations, perirenal and epididymal fat pad weights,
EER, weight gain and food intake were all significantly higher in male rats on the
48% vs. 12% fat diet. BN/fa animals had heavier fat pads than BN/BN animals.
The animals on the 48% fat diet had a significantly higher concentration of soleus
GLUT4 protein vs. 12% fat diet. We have demonstrated that a high fat diet
exacerbates insulin resistance and the aberrations associated with insulin resistance.
iv

The effects of the high fat diet are amplified in animals canying one copy of the fa
allele and female animals appear to be somewhat resistant to this diet-gene
interaction. Additionally, we have demonstrated that a high fat diet increases the
insulin responsive glucose transporter (GLUT4) protein in skeletal muscle. These
data support the concept that syndrome X is a multifactorial syndrome that
predominates in males, which is genetically determined and modulated by
environmental influences.
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PART I.
INTRODUCTION

.

. ·.

INTRODUCTION

Cardiovascular disease is one of the major killers in industrialized nations
today (Morbidity and Mortality Weekly Report 1992).

Hyperinsulinemia,

hypertension, dyslipidemia and android obesity are all considered risk factors for
cardiovascular disease. These risk factors have. a tendency to aggregate and this
combination has been coined "syndrome X" or "the deadly quartet" (Barnard et al.
1992, DeFronzo and Ferrannini 1991, Kaplan 1989, Reaven 1988). Insulin resistance
appears to be the key factor that links this "syndrome X", especially in genetically
susceptible persons (DeFronzo and Ferrannini. 1991, Reaven 1988). It- has been
shown that impaired cellular responses to insulin result in increased vascular smooth
muscle tone, decreased expression and/or translocation of the insulin-responsive
glucose transporter (GLUT4) protein, and altered transport .of glucose in skeletal
· muscle and adipose cells (Dohm et al. 1991, Ivy et al.· 1986, Kahn and Pedersen 1993,
Sherman et al.. 1988, Zemel et al. 1992).
Both clinical data and studies in animal models demonstrate. that
environmental manipulations may affect some of the symptoms associated with·
syndrome X. . For example, . physical training can improve the impaired cellular
. responses to insulin in skeletal muscle and adipose cells associated with syndrome X
(Douen et al. 1990, Friedman et al. 1990, Fushild et al. 1989, Hirshman et al. 1993,
Houmard et al. 1991, Ploug et al. 1990, Rodnick et al. -1990, Talmadge and Silverman
1991, Young et al. 1989). Physical training has been shown to induce recruitment
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and/or translocation ·of GLUT4 (Douen et al. 1990, Friedman et al. 1990, Fushiki
et al. 1989, Hirshman et al. 1993, Houmard et al. 1991, Young et al. 1989). Physical
training has also been shown to alleviate the insulin resistance associated with
android-shaped obesity (Krotkiewski and Bjomtorp 1986).

Moreover, dietary

manipulation has the potential to modify peripheral insulin sensitivity (Kahn and
Pedersen 1993, Ullioja et al. 1987, Saltin and Gollnick 1986). Rats that are obese
from high fat feeding have suppressed GLUT4 expression in skeletal muscle (Kahn
and Pedersen 1993). It has been demonstrated that a high sodium intake has the
potential to exacerbate insulin. resistance (Donovan et al. 1993). Recent research
demonstrates that manipulating fat, complex carbohydrate, and sucrose in the diet
has a profound effect on peripheral insulin sensitivity (Barnard et al. 1993). Further,
rats fed diets high in saturated fat became more obese, had elevated fasting insulin
levels and exhibited hypertension when compared with control animals and animals
on high polyunsaturated fat diets (Kaufman et al. 1994). Indeed, both activity and
diet appear to have profound effects on risk factors associated with syndrome X.
Genetics also play an important role in the etiology of syndrome X. The
obese Zucker rat is a genetically extreme animal model which exhibits some of the . ·
symptoms analogous to human syndrome X. · Insulin-resistant skeletal muscle is a
chronic defect of the obese Zucker rat (fa/fa), which is the best-known and most
widely used rat model of genetic obesity (Cortez et al. 1991, Crettaz et al.1980, Czech
et al. 1978, Ivy et al. 1989, Ivy et al. 1986, Sherman et al. 1988).· The obese Zucker
rat has also been established as a model of hypertension and insulin resistance. The
3

obese Zucker rat exhibits. obesity and hyperinsulinemia by 4-5 weeks of age (Bray
1977, Fletcher et al. 1986, Ionescu et al. 1985, Kasiske et al. 1985, Martin and
Gahagan 1977, Stem et al. 1975, Zucker and Antoniades 1972), and insulin resistance
is evident by 11-13 weeks of age (Ionescu et al. 1985). The aberrations of syndrome
X progress in this model relatively independent of environmental influences (Oeary
et al. 1980). Alternatively, the heterozygous (Fa/fa) lean Zucker rat may exhibit a
gene dosage effect which is more sensitive to environmental manipulations (Abel et
al. 1995, Figlewicz et al. 1985, Phillips and Oeary 1994, Truett et al. 1995, York et
al. 1984). Therefore, it may be a more appropriate animal model for the study of
syndrome X.
Traditionally insulin resistance associated with syndrome X has been
considered somewhat pathway selective (primarily involving glucose transport and
metabolism) -and tissue specific (primarily ·affecting skeletal muscle, adipose and
liver) (Castillo et al. 1991, DeFronzo et al. 1993, Ferrannini et al. 1987, Rocchini
1991, Zemel et al. 1992). However,· recent evidence from this laboratory and others
suggests that insulin may, in fact, exert a local vasodilatory effect on the vasculature,
which is impaired in insulin resistant states (Abel and Zemel 1993, Kim and Zemel
1993, Shehin et al. 1989, Zemel et al. 1992, Zemel et al. 1991, Zemel et al. 1990a
and 1990b). Altered glucose metabolism and associated calcium regulation appear
to be the link· between hypertension and insulin resistance in this syndrome (Abel
and Zemel 1993, Kim and Zemel 1993, Shehin et al. 1989, Zemel et al. 1992, Zemel
et al. 1991, Zemel et al. 1990a and 1990b).
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Accordingly, the focus of this dissertation research was to: (a) determine
whether aortic tissue exhibits "classical" insulin-stimulated glucose transport and if so,
is this action impaired in an insulin resistant model; and (b) determine if there is a
gene-diet interaction associated with the fa (fatty) allele, potentially modulating
GLUT4 protein and classical risk factors for syndrome X. These studies are
intended to provide insight into the interaction between genetics and environment
. and how this impacts insulin sensitivity in an animal model representative of
syndrome X.
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PART II.

LITERATURE REVIEW

SYNDROME X

Introduction

· Cardiovascular disease is one of the major killers in industrialized nations
today (Morbidity and Mortality Weekly Report 1992).

The incidence of

cardiovascular disease appears to be much more prevalent in specific groups, which
possess a clustering of anthropometric, hemodynamic and metabolic risk factors. For
example, hyperinsulinemia, hypertension, dyslipidemia and android obesity are all
considered fundamental risk factors for coronary artery disease (Barnard et al. 1992,
Basset 1994, Bjomtorp 1991, Bjomtorp 1987, DeFronzo and Ferrannini 1991, ·ua11
1994, Hall et al. 1993, Julius et al. 1992, Julius et al. 1991, Kaplan 1989, Larsson
1991, Mykkanen et al. 1992, Reaven 1988, Salvetti et al. 1993, Zemel 1995a and . ..
. 1995b).
In the Banting Lecture, Reaven (1988) suggested "there is a series of related
variables - syndrome X - that tend to occur in the same individual and may be of
enormous importance in the genesis of coronary artery disease". The common
feature of syndrome X appeared to be insulin resistance and all other changes were
secondary to this basic abnormality. · Moreover, Reaven (1988) described the related
variables (resistance to insulin-stimulated glucose uptake, glucose intolerance,
hyperinsulinemia, increased very-low-density lipoprotein triglyceride, decreased high-
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density lipoprotein cholesterol and hypertension) and proposed that a significant
portion of the variance in insulin resistance observed from person to person is
genetically determined and that insulin's action can also be modulated by
environmental influences. Hence, he proposed that life-style modifications, in
particular avoiding obesity and remaining physically active, provide an approach to
minimize the risk factors for coronary artery disease associated with resistance to
insulin-stimulated glucose uptake.
Kaplan (1989) described an analogous clustering of aberrations and coined it
the "deadly quartet".

His proposed

syndrome,

like Reaven, included glucose

intolerance, hypertriglyceridemia and hypertension. However, he also incorporated
upper-body obesity into the clustering of risk factors. He proposed that caloric
excess in the presence of androgens, mediates the aberrations by way of
hyperinsulinemia. Consequently, Kaplan (1989) suggested there was a need to
identify and prevent upper-body obesity or, provide therapies that will control the
associated problems without aggravating hyperinsulinemia.
More recently, hyperinsulinemia, hypertension, · dyslipidemia and android
obesity have been considered the fundamental risk factors converging in "syndrome
X" or the "deadly quartet" (Barnard et al. 1992, Basset 1994, Bjomtorp 1991,
Bjomtorp 1987, DeFronzo and Ferrannini 1991, Kaplan 1989, Larsson 1991,
Mykkanen et al. 1992, Reaven 1988). Apparently, insulin resistance is the key factor
that links syndrome X, especially in genetically susceptible persons (Ferrannini et al.
1990a and 1990b, Mykkanen et al. 1992, Pollare et al. 1990, Rocchini 1991, Slater
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1991, Zemel 1995a and 1995b). Reaven (1988) suggested that all of the risk factors
may not occur in every individual with insulin resistance but it is likely that the
majority of risk factors occur in most individuals. Consequently, the incidence
and/or role of insulin resistance in the etiology of the aberrations accompanying
syndrome X has been the focus of extensive investigation.

14

Syndrome X and Insulin Resistance

Several researchers have examined and confirmed the relationship between
insulin resistance and the aggregate of aberrations associated with syndrome X.
Individuals with increased fasting plasma insulin and/or incre�ed plasma insulin in
· response to a glucose challenge appear to have ·an aggregation of the aberrations
associated with syndrome X. (Ferrannini et al. 1990a and 1990b, Ferrannini et al.
1987). Swan et al. (1994) compared healthy controls to patients presenting with
· clinical syndrome X. and confirmed the relationship between insulin resistance and
the aberrations associated with this syndrome. Insulin sensitivity was 31 % lower in
men with syndrome X and fasting insulin co_ncentration was 30% higher. The patient
group also had a 64% higher mean triglyceride concentrations and a 20% lower
mean high density lipoprotein cholesterol concentration. Systolic blood pressure was
10% higher in the syndrome X group. Upon administration of an oral glucose load
Chauhan et al. (1994) found an increase in immunoreactiye insulin · levels in patients
with syndrome X when compared to an age matched control group. A similar study
by Zavaroni et. al. (1994) divided volunteers into four equal groups based on the
degree of obesity and plasma insulin response to a 74 g oral glucose challenge. The
mean integrated plasma glucose response area for 2 hours following a 75 g oral·
gluco.se load was significantly higher in the hyperinsulinemic group, as were the
fasting triglyceride levels and uric acid concentrations. In contrast, high density
lipoprotein cholesterol . concentrations were lower in the hyperinsulinemic group.
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Furthermore, systolic and diastolic · blood pressures were higher in the
hyperinsulinemic group. Division of the two groups into obese and non-obese
subjects did not alter the differences outlined above. In a subsequent study by
Zavaroni et al. (1993), 20 males with asymptomatic hyperuricemia and 20 males with
normal serum uric acid concentrations received a 75 g oral glucose challenge. The
plasma glucose and insulin responses to the oral glucose was increased in the
hyperuricemia group, as were systolic and diastolic blood pressures. In addition,
subjects with hyperuricemia had higher plasma triglycerides · and cholesterol and
lower high density lipoprotein cholesterol concentrations. The authors provided
· these results as a possible explanation for the well known association . of
hyperuricemia · with coronary heart disease.

Furthermore, they suggested · that

hyperuricemia be added to the cluster of metabolic and hemodynamic abnormalities
. associated with insulin resistance, hyperinsulinemia and -syndrome X.
Several researchers (Bjomtorp 1992, Bjomtorp 1991, Bjomtorp 1987, Haffner
et al. 1990, Kaplan 1989,. Mbanya et al� 1988; Mykkanen et al. 1992) have examined
and postulated on the relationship between obesity and syndrome

x.· It appears

android obesity, indicated by waist/hip circumference ratio, is a risk factor for
. cardiovascular disease, in parallel with other previously established risk factors. The
important component of waist/hip ratio appears to be the mass of visceral fat,
relatively independent of total fat mass. Bjomtorp ( 1992, 1991 and 1987) postulated
that visceral fat mass is probably increased by multiple endocrine aberrations, with
· steroid hormones involved in the basic etiology of these aberrations. Moreover, this
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appears to cause insulin resistance by direct effects on the periphery, which may be
amplified by the metabolism of the enlarged visceral adipose tissues. Hence, this
association of insulin resistance and android obesity is consistent with Kaplan's (1989)
initial hypothesis and may therefore be considered one of the primary aberrations
likely to occur in syndrome X.
The relationship between syndrome X and insulin resistance has been assessed
in several diverse populations. Chaiken et al. (1993) assessed the relationship
between insulin resistance and the other aberrations associated with syndrome X in
37 black men and 53 black women with NIDDM. In the total group 30% - were ·
insulin sensitive and 70%
were insulin resistant. No relationship existed betweei;i
'
.
insulin sensitivity and blood pressure in either sex. However, fasting triglyceride and ·
high density lipoprotein cholesterol levels · were highly correlated in an inverse
relationship within men, but not women. In summary, blood pressure did not
· correlate with insulin resistance in blacks with NIDDM.
Stem et al. (1992) examined the San Antonio Heart Study cohort, a·
population-based cohort of 3,301 Mexican Americans and 1,857 non-Hispanic whites.
The researchers defined individuals who were hyperdynamic (pulse pressure and
heart rate in the upper quartile of their respective distributions), intermediate, and
hypodynamic (pulse pressure and heart· rate in the bottom quartile). . The
characteristics of syndrome X were examined according to the previously defined
. hemodynamic categories, as was the 8-year incidence of hypertension and NIDDM.
A hyperdynamic circulation was significantly associated with an increase. in body mass
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index, subscapular-to-tricep skinfolds ratio, triglyceride, 2-hour glucose, and insulin. .
When the groups were broken down into obese and non-obese individuals the above
effects persisted. The odds ratio for the hyperdynamic state as a predictor of future
NIDDM was significant, but this was not true for hypertension. Haffner et al. (1990
and 1992) also used the population-based San Antonio Heart study to examine the
relationship of fasting insulin concentration to the incidence of multiple metabolic
abnormalities associated with syndrome X. In multivariate analyses, after adjustment
for obesity and body fat distribution, elevated fasting insulin continued to be
significantly related to decreased high density lipoprotein cholesterol, increased
triglycerides and the increased in�dence of NIDDM.
Baseline insulin concentrations
.
.

were higher in subjects who subsequently developed multiple metabolic disorders.
. The results could not be attributed to differences in baseline obesity and were similar
in Mexican Americans and non-Hispanic whites. The previous results support the
existence of a syndrome related to multiple metabolic disorders, which reveal that
elevations in insulin concentration precede the development of numerous metabolic
disorders.
Additionally, Saad et al. (1991) examined racial differences in the relation
between blood pressure and insulin resistance. Pima Indians, whites, and blacks who
were normotensive and . did not have diabetes were screened for insulin resistance
using the euglycemic-hyperinsulinemic clamp technique. The Pima Indians had
higher fasting plasma insulin concentrations and lower rates of whole-body glucose
disposal than whites or blacks. After adjustment for age, sex, body weight, and
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percentage. of body fat, mean arterial blood pressure was significantly correlated with
fasting plasma insulin concentration andlrate of glucose disposal in whites, but not
Pima Indians or blacks. The authors concluded that the relationships among
insulinemia, insulin resistance and blood pressure differ among racial groups and may
be mediated by mechanisms active in whites, but not in Pima Indians or blacks.
Falkner et al. (1990) investigated blood pressure in young black men to determine
if insulin resistance was an antecedent to hypertension. The results ·revealed a
relationship between insuli�-mediated glucose uptake and blood pressure.
Furthermore, in this young black population insulin resistance appears to precede the
onset of established essential hypertension. In conclusion, insulin resistance appears .
to be under genetic controi although genetic predisposition alone can not account
for the prevalence of hypertension against a divergent ethnic background. (Ferrannini
et al. 1990a and 1990b, Ferrannini et �� 1987).
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Insulin Signalling and Insulin Resistance

Insulin acts on several tissues to elicit several metabolic effects. The insulin
molecule consists of two polypeptide chains connected by two disulfide bridges. Most
mammalian insulin molecules have similar sequences; in fact, the primary structure
of insulin has been relatively stable throughout evolution. Insulin is formed from a
biosynthetic precursor of a high molecular weight, proinsulin. Recently, it has been
demonstrated that insulin binds to the a subunit of its receptor,, which results in the
autophosphorylation of the p subunit and activation of ·the p subunit tyrosine kinase.
This .elicits a cascade of phosphorylation and dephosphorylation. For example,.
ribosomal protein S6 and acetyl-CoA-carboxylase �e · phosphorylated, whereas .
· pyruvate dehydrogenase and glycogen synthase are dephosphorylated. Moreover,
after insulin binds to its receptor and activates tyrosine kinase, it stimulates glucose
transport by . promoting the translocation and/or activation of transport proteins.
Further, it is believed that following activation of insulin receptor · tyrosine kinase,
there is a site-specific phosphorylation and activation of phosphoserine phosphatase1. Hence, phosphoserine phosphatase-1 dephosphorylates a number of intracellular
substrates of insulµi action, including GLUT4, which leads to activation of this
glucose transporter. Insulin also exerts an effect on the transcription . of specific
mRNAs. Furthermore, subsequent to receptor kinase activity insulin . may generate
second messengers (insulin receptor substrate. l, IRS-1) that would modulate some
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of the effects of insulin within the cell (Baulieu and Kelly 1990, Begum et al. 1993,
Quon et al. 1994, Saltiel 1990).
Initially, insulin's action was thought to primarily be the enhancement of
glucose disposal in skeletal muscle via insulin sensitive transporters. Hence, this
launched the investigation of glucose transport in classical insulin sensitive tissues.
This led to the recognition of GLUT4 as the primary insulin-stimulated glucose
transporter, which is present in adipose tissue, cardiac and skeletal muscle. More
recently, GLUT4 has been found in A-10 vascular smooth muscle cells, renal vascular
cells and glomerular cells (Cooper et al. 1993, Marcus et· al. 1994). Subsequent
studies revealed
. that .GLUT4 is activated and/or translocated by an insulin induced
.

.

second messenger possibly IRS-1 (Quon et al. 1994). Moreover, there may be a
direct . interaction between the actin network and glucose transporter vesicles which
may be mediated through a spectrin-containing skeleton . attached to glucose
. transporter-containing vesicles (Tsakiridis et al. 1994). In addition, GLUT4 appears
to be the transporter responsible for exercise-induced, insulin independent glucose
uptake. ·
· The two primary glucose transporters found in skeletal muscle are GLUTl
and GLUT4. It appears that · GLUTl is not insulin responsive and functio� to
maintain the basal uptake of glucose into skeletal muscle (Barnard · and Youngren ·.
1992). In contrast, the insulin-responsive GLUT4 is recruited when elevated glucose
levels elicit an increase in circulating insulin. Furthermore, non-insulin contractile
mediated glucose uptake associated with exercise may utilize a separate pool of
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GLUT4 transporters, since the combination of insulin-induced and exercise-induced
glucose uptake is additive (Barnard and Youngren 1992). The proposed mechanism
of GLUT4 activation suggests that GLUT4 is present in tubulovesicular structures
clustered in the transgolgi reticulum and that these transporters are translocated to
the sarcolemma with either insulin stimulation and/ or exercise (Barnard and
· Youngren 1992, Galante et al 1994,' Holman et al. '1994).

It also has been ·

demonstrated (Kainulainen et al. 1993) that there is a marked difference · in the
response of glucose transport to hypoinsulinemia between oxidative· and glycolytic
fibers. Furthermore, in contrast to GLUTl, GLUT4 levels are regulated similarly
in sever� tissues (heart and sk�letal muscle) in response to hypoinsulinemia.
Additionally, it has been demonstrated that increases in cytoplasmic

ea2+

concentration too low to elicit muscle contraction induce an increase in glucose
transport activity in skeletal muscle (Youn et al. 1991). On the other hand, Begum
et al. (1993) demonstrated in adipocytes that elevated levels of cytosolic calcium
· interfere with insulin's ability to dephosphorylate GLUT4, thus reducing· its intrinsic
activity. Moreover, it has been ·demonstrated in adipocytes that there is an optimal
range of cytosolic free calcium for insulin-stimulated glucose transport .(Draznin et .
al. 1987, Levy et al. 1989). Thus, cellular calcium homeostasis appears to be linked
to classical actions of insulin in skeletal muscle and adipocytes. It has been proposed
that sustained levels of intracellular

ea2+ inhibit phosphoserine phosphatase-1 via the

phosphorylation and activation of its inhibitor. This effect appears to be mediated
by cAMP-dependent pathways. Thus, inhibition of phosphoserine phosphatase-I
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activity results in impaired dephosphorylation of several insulin-sensitive enzymes and
proteins such as glycogen synthase and GLUT4 (Begum et al. 1992).
Traditionally insulin resistance has been considered pathway specific (primarily
involving glucose transport and metabolism) and tissue specific (primarily affecting
skeletal muscle, adipose, and liver tissues) (Castillo et al. 1991, Defronzo et al. 1993,
Ferrannini et al. 1987, Rocchini 1991, Zemel et al. 1992). However, . recent data
· suggest there are other "non-classical" insulin sensitive pathways (calcium
metabolism) and tissues (vascular smooth muscle) which are affected in insulin
resistance (Abel and Zemel · 1993, Kim and Zemel . 1993, Marcus et al. 1994, Quon
et al.. 1994, Shehin et al. 1989, Zemel et al. .1992,. Zemel et al. 1991, Zemel et al.
1990a and 1990b).
The demonstrated elevations in blood pressure accompanying insulin resistant
states have been attributed to a lack of feedback inhibition for insulin release,
resulting in hyperinsulinemia and consequent increases in sympathetic output (Hall
et al. · 1989). However, recent evidence from several laboratories, indicates that
insulin exerts a direct local vasodilatory effect on the vasculature, and this effect is
impaired in insulin resistant states (Kim and Zemel 1993, Shehin et al. 1989, Zemel
et al. 1991, Zemel et al. 1990a and 1990b). Insulin accelerates the rate of vascular
smooth · muscle recovery from pressor agonist-induced intracellular free calcium
transients, while these recovery rates are blunted in both insulin resistant and
insulinopenic rats (Abel and Zemel 1993a and 1993b, Kim and Zemel 1993).
Similarly, insulin attenuates vascular reactivity responses to pressor agonists, as both
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insulin resistant and insulinopenic animals exhibit exaggerated vascular reactivity
(Reddy at al. 1990, Zemel et al. 1990a). Further, it has been recently demonstrated
that some of these effects are dependent, in part, upon glucose transport and/ or
metabolism (Kim and Zemel 1995).
In conclusion, there appears to be an accumulating body of evidence that
insulin may have "non-classical" actions on a tissues that are · not traditionally
considered insulin sensitive. Moreover, it appears that insulin acts as a vasodilator
in vascular smooth muscle (via regulation of calcium transport and cellular calcium
levels) and this action is blunted or lost in insulin resistant states (Zemel 1995a and
1995b).
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Insulin Resistance and Environmental Influences

As previously mentioned, environmental manipulations may alleviate some of
the symptoms associated with syndrome X. For example, physical training can
improve the impaired cellular responses to insulin in skeletal muscle and adipose
cells associated with syndrome X (Douen et al. 1990, Friedman et al. 1990, Fushiki
et al. 1989, Hirshman et al. 1993, Houmard et al. 1991, Ploug et al. 1990, Rodnick
et al. 1990, Talmadge and Silverman 1991, Young et al. 1989). Physical training has
been shown to induce recruitment and/or translocation of GLUT4 (Douen et al.
1990, Friedman et al. 1990, Fushiki et al. 1989, Hirshman et al. 1993, Houmar_d et
al. 1991, Young et al. 1989). Physical training has also been shown to alleviate the
insulin resistance associated with android-shaped obesity (Krotkiewski and Bjomtorp
1986). Moreover, dietary manipulation has the potential to modify peripheral insulin
sensitivity (Kahn .and Pedersen 1993, Lillioja et al. 1987, Saltin and Gollnick 1986).
Rats that are obese from high fat feedings have a suppression of GLUT-4 expression
in skeletal muscle (Kahn and Pedersen 1993). It has been demonstrated that a high .
sodium intake has· the potential to exacerbate insulin resistance (Donovan et al.
1993). Recent research demonstrates that manipulating fat, complex carbohydrate,
and sucrose in the diet has a profound effect on peripheral insulin sensitivity
(Barnard et al. 1993). Further, rats fed diets high in saturated fat became more
obese, had elevated fasting insulin levels and exhibited hypertension when compared
with control animals and animals on high polyunsaturated fat diets (Kaufman et al.
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1994). Therefore it appears that insulin resistance is the locus of a multifactorial
syndrome that is genetically based, but modifiable by environmental manipulation
(Henriksen et al. 1994, Martin et al. 1991, Serjeantson and Zimmet 1991). This gene
environment interaction will be addressed in greater detail in subsequent sections.
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ANIMAL MODELS OF SYNDROME X

Introduction

·There are several animal models exhibiting genetic mutations which result in
obesity and/or insulin resistance. In the mouse the ob/ob, db/db andA\.1/·, whereas,
in the rat the fa/fa, ZDF/Drt-fa, JCR:IA-ca and SHR/N-cp are commonly used
models of genetic obesity and insulin resistance. Analogous to the human syndrome
X, these rodent models of obesity possess a clustering of risk factors revolving around
insulin resistance. For example, hyperinsulinemia, hypertension, dyslipidemia and
obesity appear together in several of these models (Apweiler et al.1993, Johnson et
al. 1991, Kasiske et al. 1992, Kava et al. 1990, Paulson et al. 1992, Pederson et al.
1991, Truett et al. 1991, Zemel et al. 1995c, Zhang et al. 1994).
The main focus of this section will be on the obese Zucker rat (fa/fa), a
genetically extreme animal model which exhibits some of the symptoms analogous
to human syndrome X (Apweiler et al. 1993, Kasiske et al. 1992, Kava et al. 1990,
Paulson et al.1992). The obese Zucker rat model was discovered in 1961 by Zucker
and Zucker. This has been the most extensively studied model of obesity in terms
of metabolic and cardiovascular alterations (Paulson et al.1992). Obese Zucker rats
exhibit many of the classical cardiovascular risk factors: hyperlipidemia,
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hyperinsulinemia, insulin resistance, impaired glucose tolerance and debatable
hyperglycemia and hypertension (Paulson et al. 1992).
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The Zucker Rat as a Genetic Model of Syndrome X

It has been speculated that the obesity gene fatty (fa) of the Zucker rat has
homology with the mouse gene diabetes (db) and that a homolog of the fa and db
gene is likely to occur in humans (Truett et al. 1991). Moreover, with the recent
cloning of the mouse obese (ob) gene and its human homologue� - the putative role
of the fa gene becomes much more apparent. It has been speculated (Zhang et al.
1994) that the ob gene· product is a signal molecule that regulates. body weight,
potentially interacting with central nervous system and/or other receptors to
modulate food intake and the activity of the autonomic nervous system.
Furthermore, experiments suggest that the ob receptor is encoded by the mouse db
gene (Zhang et al. 1994). Hence, the fa gene may code for the obese (the
unidentified rat homologue of ob?) receptor in the Zucker rat (Truett et al. 1991).
Insulin-resistant skeletal muscle is a chronic defect of the obese Zucker rat
(fa/fa)', (Apweiler et al. 1993, Cortez et al. 1991, Crettaz et al. ·1980, Czech et al�

1978, Ivy et al. 1989, Ivy et al. 1986, Kasiske et al. 1992, Kava et al. 1990, Paulson et
at 1992, Sherman et al. 1988, Zucker and Antoniades 1972). The obese Zucker rat
has also been established as a model of hypertension and insulin resistance (Ionescu
et al. 1985, Kurtz et al. 1989, Shehin et al. 1989, Yoshioka et al. 1993, Zemel et al.
1992, Zemel et al. 1990a and 1990b). The obese Zucker rat exhibits obesity (present
in obese Zucker rats when compared to lean (Fa/?) siblings) and hyperinsulinemia
by 4-5 weeks of age (Bray 1977, Fletcher et al. 1986, Ionescu et al. 1985, Kasiske et
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al. 1985, Martin et al. 1977, Stem et al. 1995, Zucker and Antoniades 1972), and
insulin resistance is evident by 11-13 weeks of age (Ionescu et al. 1985).
Hyperglycemia appears to be dependent on the specific colony of obese Zucker rats,
as some colonies exhibit hyperglycemia and others do not (Bray 1977, Ionescu et
al. 1985). Nonetheless, skeletal muscle glucose transport is lower in obese animals
(Cortez et al. 1991, Ivy et al. 1989, Sherman et. al. 1988). Obese Zucker rats also
exhibit hyperphagia which plateaus with · maturation. The relative hyperphagia is
influenced by dietary components, as animals on a high fat _diet reach this plateau
earlier (Vasseli and Maggio 1990). Although the obese Zucker rat has been
extensively studied as a model of hypertension, findings of obese versus lean. Zucker
rats are conflicting consistent with hypertension in human syndrome X. On the other
hand, direct arterial measurements in conscious, unrestrained animals demonstrate
that obese Zucker rats are hypertensive by six weeks of age (Kurtz et al. 1989,
Shehin et al. 1989, Yoshioka et al. 1993, Zemel' et al. 1992, Zemel et al. 1990a and·
1990b). Moreover, vascular smooth muscle from obese animals exhibits increased
in vitro vascular reactivity (Zemel et al. 1990a) and exaggerated intracellular calcium
responses to vasoactive agonists compared to lean animals (Abel and Zemel 1993).
Distinguishing between genotypes · of lean and obese Zucker rats has been.
relatively impossible until later in maturation, when phenotypic markers (rectal
temperature, body weight and fat pad size) are discernible.

Furthermore,

distinguishing between homozygous (Fa/Fa) and heterozygous (Fa/fa) lean animals
has been dependent on the known breeding history of parent animals, which appears
30

problematic in regard to controlling for the litter effect (Truett et al. 1995) and the
unequivocal identification of pure Fa/Fa and Fa/fa populations. Consequently, little
research has been done to examine gene dosage effects of the fa allele. Nonetheless,
a few studies have shown lean heterozygote animals to be phenotypically
intermediate on several physical and metabolic parameters (Baskin et al. 1985, Blonz
et al. 1985, Figlewicz et al. 1985, Phillips and Cleary 1994, York et al. 1984, Truett
et al. 1995, Abel et al. 1995).· Phillips and Cleary (1994) examined lean (Fa/Fa,

Fa/fa) and obese Zucker (fa/fa) rats at 17 days of age. They determined inguinal
fat pad weight, inguinal fat pad weight/body weight ratio and inguinal fat pad cell
size and number.

It was demonstrated that lean Zucker heterozygotes were

intermediate between obese and homozygote lean Zucker pups. Furthermore, lipid
metabolic enzymes such as lipoprotein lipase and 6-phosphogluconate dehydrogenase
were also intermediately produced in adipose and liver tissue. Baskin et al. (1985)
demonstrated that insulin binding in brain and liver is reduced in both lean
heterozygote and obese animals when compared to lean homozygote animals.
Figlewicz et al. ( 1985) also demonstrated that brain and liver insulin binding . is
decreased in Zucker rats carrying the fa gene. Moreover, dynamic pancreas release
of insulin is increased in lean heterozygote and obese rats compared to homozygote
lean Zucker rats (Blonz et al. 1977).

Intermediate effects have also been

demonstrated in brown adipose tissue thermogenesis when lean Zucker homozygous
and obese Zucker rats were compared with lean Zucker heterozygous rats (York et
al. 1984). Truett et al. (1995) demonstrated a codominant effect of the fa gene
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during early development of obesity. At 14-days-of-age, fa copy number had linear
effects on body, inguinal adipose pads and interscapular brown adipose tissue
weights. The · recessive effects of the fa on growth appear during the second week
of life. Furthermore, these effects became much more dramatic when the litter effect
was statistically controlled. Recent findings from our laboratory (Abel et al. 1995)
indicate that feeding lean animals a high fat diet unmasked heterogeneity in mean
arterial blood pressure, plasma insulin and glucose, and food efficiency. The
variability in mean arterial blood pressure was correlated with blood glucose and
food efficiency in high fat fed rats. Lean animals fed a high fat diet with the highest
mean arterial blood pressures also had higher circulating insulin and glucose as well
as a higher food efficiency ratio. The ability of a high fat diet to raise mean arterial
blood pressure was related to the ability of a high fat diet to exert a diabetogenic
effect and possibly promote fat storage. Thus, we observed two populations of lean
animals, which suggests a fa gene dosage effect being environmentally altered in
heterozygous (Fa/fa) animals.
Orosco et al. (1991) investigated the effect of insulin on brain monoamine
metabolism in the Zucker rat. It has been postulated that disturbances of insulin or
brain monoamine metabolism may play a role in the impaired regulation of food
intake and body weight in the obese Zucker rat. Accordingly, the researchers
investigated a possible insulin-monoamine interaction by measuring monoamine
levels in the hypothalamus and striatum of obese (fa/fa) and lean (Fa/Fa,Fa/fa)
Zucker rats after peripheral insulin administration. The classical effect of insulin
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(increased monoamines) was observed in the hypothalamus of lean (Fa/Fa,Fa/fa)
rats, but not obese rats. Furthermore, insulin administration increased monoamine
levels in the striatum of the lean (Fa/Fa) rats only, suggesting a central insulin
related disturbance related to the presence of the "fa" gene. In addition, certain
effects of insulin on striatal dopamine release were observed in only the Fa/Fa and
fa/fa rats, suggesting a particular disturbance related to the heterozygous character.
In conclusion, there appears to be an accumulating body of evidence that suggests
a gene dosage effect related to the fa allele. Moreover, it appears that this effect
may be manipulated by environmental factors (Abel et al. 1995).
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The IA>Cus of Insulin Resistance in The Zucker Rat

As previously mentioned insulin's action is elicited by the molecule binding
to the a subunit of its receptor, which results in the autophosphorylation of the p
subunit and activation of the p subunit tyrosine kinase. This elicits a cascade of
phosphorylations and dephosphorylations.

Moreover, after insulin binds to its

receptor and activates tyrosine kinase, it stimulates glucose transport by promoting
the translocation and/or activation of transport proteins. Insulin also exerts an effect
at the gene level, on the transcription of specific mRNAs. One example of this is the
expression of

ea2+ ATPase in vascular smooth muscle (Zemel 1995a). Furthermore,

subsequent to receptor kinase activity insulin generates second messengers that ·
modulate some of the effects of insulin within the cell (Baulieu and Kelly 1990,
Saltiel 1990). Insulin-resistant skeletal muscle is a chronic defect of the obese
Zucker rat (fa/fa) (Cortez et al. 1991, Crettaz et al.1980, Czech et al. 1978, Ivy et al.
1989, Ivy et al. 1986, Kasiske et al. 1992, Sherman et al. 1988). The obese Zucker
rat is a well established model of hypertension and insulin resistance. The obese
Zucker rat exhibits obesity and hyperinsulinemia (Bray 1977, Fletcher et al. 1986,
Ionescu et al. 1985, Kasiske et al. 1985, Martin and Gahagan 1977, Stem et al. 1975,
Zucker and Antoniades 1972), and insulin resistance early in life (Ionescu et al.
1985). The metabolic and hemodynamic alterations progress in the obese Zucker rat
relatively independent of environmental manipulation (Oeary et al. 1980).

34

Skeletal muscle is one of the traditional sites for insulin's action and is the
primary insulin-induced disposal site for glucose. Approximately 75-80% of glucose
removed from the blood under maximal insulin stimulation goes into skeletal muscle
(Barnard and Youngren 1992). Furthermore, most of the diseases associated with
syndrome X exhibit insulin resistance in skeletal muscle as one of their primary
characteristics (Barnard and Youngren 1992, Dohm 1991, Elsas and Longo 1992,
Kaplan 1989, Pessin and Bell 1992). . Both glucose .transport and GLUT4 protein
function in skeletal muscle of the obese Zucker rat appear to be defective relative
to lean littermates (Brozinick et al. 1994). Thus, many researchers have examined
the mechanisms of altered insulin-induced glucose disposal in skeletal muscle of the
obese Zucker rat. A primary focus of this laboratory has been the role of insulin in
regulating vascular smooth muscle reactivity and cell calcium regulation (Abel et al.
1993b, Kim and Zemel 1993, Zemel et al. 1992, Zemel et al. 1991, Zemel et al.
1990a and 1990b). This regulation is blunted or lost in insulin resistant states, as
these "non-classical" actions of insulin are not well preserved in vascular smooth
muscle of insulin resistant animals (Abel et al. 1993b, Zemel et al. 1991, Zemel et
al. 1990a and 1990b). In conclusion, it appears that insulin resistance is inherent in
the obese Zucker rat. Moreover, this resistance to insulin is manifested in traditional
skeletal muscle carbohydrate metabolism and in additional pathways of other tissues
such as vascular smooth muscle. The locus of altered insulin-stimulated glucose
disposal in the obese Zucker rat will be addressed in subsequent sections.
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Environmental Influences on Insulin Resistance in Syndrome X and the Zucker Rat

There is limited research addressing environmental modulation of insulin
resistance in syndrome X and the obese Zucker rat. Further, most of the research
has focused on manipulating activity, while limited studies have addressed dietary
manipulation. For example, physical training can improve the impaired cellular
responses to insulin in skeletal muscle and adipose cells associated with syndrome X
(Douen et al. 1990, Friedman et al. 1990, Fushiki et al. 1989, Hirshman et al. 1993,
Houmard et al. 1991, Ploug et al. 1990, Rodnick et al. 1990, Talmadge and Silverman
1991, Young et al. 1989). Physical training has been shown to induce recruitment
and/or translocation of GLUT4 (Douen et al. 1990, Friedman et al. 1990, Fushiki
et al. 1989, Hirshman et al. 1993, Houmard et al. 1991, Young et al. 1989). Physical
training has also been shown to alleviate the insulin resistance associated with
android-shaped obesity (Krotkiewski and Bjomtorp 1986).

Moreover, dietary

manipulation has the potential to modify peripheral insulin sensitivity (Kahn and
Pedersen 1993, Lillioja et al. 1987). Rats that are obese from high fat feedings have
a suppression of GLUT-4 expression in skeletal muscle (Kahn and Pedersen 1993).
In addition, a high sodium intake has the potential to exacerbate insulin resistance
(Donovan et al. 1993). likewise, manipulating fat, complex carbohydrate, and
sucrose in the diet has a profound effect on peripheral insulin sensitivity (Barnard
et al. 1993). Further, rats fed diets high in saturated fat became more obese, had
elevated fasting insulin levels and exhibited hypertension when compared with
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control animals and animals on high polyunsaturated fat diets (Kaufman et al. 1994).
The details of environmental manipulation of glucose transport and GLUT4 will be
addressed in subsequent sections.
As previously mentioned the Zucker rat is a genetic rodent model which
exhibits insulin-resistance in skeletal muscle as a chronic defect of the obese rat
(fa/fa) (Cortez et al. 1991, Crettaz et al.1980, Czech et al. 1978, Ivy et al. 1989, Ivy
et al. 1986, Sherman et al. 1988). The obese Zucker rat has also been established
as a model of hypertension and insulin resistance. The obese Zucker rat exhibits
obesity and hyperinsulinemia by 4-5 weeks of age (Bray 1977, Fletcher et al. 1986,
Ionescu et al. 1985, Kasiske et al. 1985, Martin and Gahagan 1977, Stem et al. 1975,
Zucker and Antoniades 1972), and insulin resistance is evident by 11-13 weeks of age
(Ionescu et al. 1985). The aberrations of syndrome X progress in this model
relatively independent of dietary influences (Cleary et al. 1980), although, it has been
demonstrated that specific aberrations can be blunted with exercise (Brozinick et al.
1993).
Alternatively, Smoller et al. (1993) has recently discovered a restriction
fragment length polymorphism corresponding to a cDNA library clone (VC85) in .
Brown Norway/Zucker offspring. Therefore, distinguishing between obese (fa/fa),
lean homozygous (BN/BN) and lean heterozygous (BN/fa) animals is possible.
Accordingly, it is now possible to determine if/a gene dosage alters the severity and
developmental progress of obesity, insulin resistance, hyperglycemia, dyslipidemia and
hypertension.
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In conclusion, the aberrations of syndrome X progress in the Zucker model
(fa/fa) relatively independent of environmental influences (Cleary et al. 1980).

Alternatively the heterozygous (Fa/fa) lean _Zucker rat may exhibit a gene dosage
effect which may be more sensitive to environmental manipulations (Figlewicz et al.
1985, Phillips and Cleary 1994, York et al. 1984). Therefore, the heterozygous lean
Zucker rat may be a more appropriate animal model for the study of gene
environment interaction in syndrome X than the genetic extreme obese Zucker rat.
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GLUCOSE TRANSPORTERS. AND TRANSPORT IN INSULIN RESISTANT
STATES

Introduction

Glucose transport appears to be the rate-limiting step for glucose disposal in
skeletal muscle. Glucose uptake is maximized by the presence of . insulin and/or
muscle contraction, which are additive and appear to be independent of each other
and tissue specific (Brozinick et al. 1994, Brozinick et al. 1992, King et al.1993, King
et al. 1992).

Furthermore, in muscle and adipose tissue, glucose transport is

regulated by intrinsic and extrinsic factors (Rodnick et al. 1992). Several glucose
transporter proteins work together to maintain glucose homeostasis in the body by
balancing glucose absorption with glucose utilization (Elsas and Longo 1992, Pessin
and Bell 1992). The glucose transporter proteins can be divided into two main
classes which include the sodium-dependent glucose cotransporters (SGTPl) and the
facilitative glucose transporters (GLUTl-GLUTS). The sodium-dependent glucose .
cotransporters transport glucose against a. concentration gradient inside intestinal and
renal cells using the electrochemical potential of sodium as their energy source (Elsas
and Longo 1992). Since glucose is a hydrophilic molecule and cannot freely cross the
plasma membrane, a . series of facilitative glucose transporters are required to
promote entry of glucose into cells. The facilitative glucose transporters transport
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glucose down a concentration gradient and do not require energy (Barnard et al.
1992a and 1992b, Elsas and Longo 1992).
The first glucose transporter (GLUT1) is located in brain, erythrocyte, and
fibroblast cells and is minima11y stimulated by insulin. The primary purpose of
GLUT1 is to maintain basal glucose transport in the cell. On the other hand,
GLUT2 is a low affinity glucose transporter found primarily in liver, kidney, intestine,
and p cells. GLUT2 activity increases when blood glucose levels are elevated beyond
the basal state. GLUT3 has a function (basal glucose transport) similar to GLUT1
and is also found in brain and fibroblast cells. GLUT4 is the primary insulin
stimulated glucose transporter and is found in adipose tissue, cardiac muscle, and
skeletal muscle (Barnard and Youngren 1992, Elsas and Longo 1992, Pessin and Bell
1992).
More recently, GLUT4 has been found in A-10 vascular smooth muscle cells,
renal vascular cells and glomerular cells (Cooper et al. 1993, Marcus et al. 1994).
GLUT4 is activated and/or translocated by an insulin induced second messenger.
Subsequent demonstration revealed that GLUT4 is activated and/ or translocated by
an insulin induced second messenger possibly IRS-1 (Quon et al. 1994). Moreover,
there may be a direct interaction between the actin network and glucose transporter
vesicles which may be mediated through a spectrin-containing skeleton attached to
glucose transporter-containing vesicles (Tsakiridis· et al. 1994). Furthermore, it has
been demonstrated that increases in cytoplasmic

ea2+ concentration too low to cause

muscle contraction can induce an increase in glucose transport activity in skeletal
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muscle (Youn et al. 1991 ). On the other hand, Begum et al. ( 1993) demonstrated
in adipocytes that elevated levels of cytosolic calcium interfere with insulin's ability
to dephosphorylate GLUT4, thus reducing its intrinsic activity. Moreover, it appears
there is an optimal calcium range for some of insulin's actions. It has been
demonstrated in adipocytes that there is an optimal range of cytosolic free calcium
for insulin-stimulated glucose transport (Draznin et al. 1987, Levy et al. 1989), thus,
linking cellular calcium homeostasis to classical actions of insulin in skeletal muscle
and adipocytes. It has also been proposed that sustained levels of intracellular

ea2+

inhibit phosphoserine phosphatase-I via the phosphorylation and activation of its
inhibitor. This effect appears to be mediated by cAMP-dependent pathways. Thus,
inhibition of phosphoserine phosphatase-I activity elicits impaired dephosphorylation
of several insulin-sensitive enzymes and proteins such as, glycogen synthase and
GLUT4 (Begum et al. 1992). GLUT4 also appears to be the transporter responsible
for exercise-induced insulin independent glucose uptake.
The final glucose transporter (GLUTS) is located in the small intestine and
facilitates the absorption of glucose from the lumen. Although much progress has
been made in understanding the specific glucose transporters, there are still many
important unanswered questions (Barnard and Youngren 1992, Elsas and Longo
1992, Pessin and Bell 1992).
The two primary glucose transporters found in skeletal muscle and adipocytes
consist of GLUTl and GLUT4. It appears that GLUTl functions to maintain the
basal uptake of glucose into skeletal muscle (Barnard and Youngren 1992), whereas
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GLUT4 is recruited when elevated glucose levels elicit an increase in circulating
insulin. GLUT4 also appears to be responsible for non-insulin mediated glucose
(contractile) uptake associated with exercise. This phenomena may utilize a separate
pool of GLUT4 transporters since the combination of insulin-induced and exercise
induced glucose uptake is additive (Barnard and Youngren 1992). The proposed
mechanism on how GLUT4 is activated suggests that GLUT4 is present in
tubulovesicular structures clustered in the transgolgi reticulum and that these
transporters are translocated to the sarcolemma with either insulin stimulation
and/or exercise (Barnard and Youngren 1992, Galante et al 1994, Holman et al.
1994). It also has been demonstrated (Kainulainen et al. 1993) that there is a
marked difference in the response of glucose transport between oxidative and
glycolytic fibers. Furthermore, GLUTl and GLUT4 levels are regulated differently
in various tissue types.
. Skeletal muscle is the primary insulin-induced disposal site for glucose.
Approximately 75% of glucose removed from the blood under maximal insulin
stimulation goes into skeletal muscle (Barnard and Youngren 1992). Furthermore,
most of the diseases associated with altered insulin-induced glucose disposal have
insulin resistance in skeletal muscle as one of their primary characteristics (Barnard
and Youngren 1992, Dohm 1991, Elsas and Longo 1992, Kaplan 1989, Pessin and
Bell 1992). Both glucose uptake and GLUT4 protein distribution in skeletal muscle
of NIDDM and the obese Zucker rat appear to be defected (Brozinick et al. 1994,
Wallberg et al. 1992). Thus, many investigators have focused their research on
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impaired insulin-induced glucose disposal in skeletal muscle. Moreover, with GLUT4
being one of the primary regulators of insulin and contractile-induced glucose
disposal, it has become the locus of extensive research. Therefore, the emphasis of
this section will be to examine the effects of environmental manipulations such as
exercise training and diet on insulin-sensitivity and GLUT4 regulation in skeletal
muscle and adipocytes. Furthermore, the interaction of exercise and the glucose
transport system has been investigated much more extensively then the interaction
of diet and the glucose transport system, thus, it is logical to examine both
interactions in this section.
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Environmental Influences on Glucose Transport and GLUT4

Exercise

It been shown that increasing the expression and/or insulin-induced
translocation of GLUT4 is beneficial for individuals that possess any disease that
encompasses a glucose disposal abnormality. Moreover, it appears that skeletal
muscle GLUT4 aberrations result from a defect in GLUT4 compartmentalization,
translocation and/or functional activity, and there appears to be a divergence
between GLUT4 mRNA levels and translation (Garvey et al. 1991, Garvey et al.
1992a and 1992b, Hager et al. 1991, Hainault et al. 1991, Kahn et al. 1992a and
1992b, King et al. 1992, Knott 1992). Hence, several researchers have investigated
the potential benefit of exercise training in increasing glucose transport, GLUT4
· activity and GLUT4 translocation in insulin resistant models (Garvey et al.. 1991,
Garvey et al. 1992a and 199 2b, Hager et al. 1991, Hainault et al. 1991, Kahn et al.
1992a and 1992b, King et al. 1992, Knott 1992).
Several investigators have demonstrated that exercise has the potential to
ameliorate the defects in glucose transport and/or GLUT4 associated with syndrome
X and a sedentary lifestyle. For instance, Dela et al. (1994) demonstrated that
physical training increased muscle GLUT4 protein and mRNA in patients with
NIDDM. Seven men with NIDDM and eight healthy controls were cycle trained and
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biopsies were obtained from the vastus lateralis leg muscle before and after the
training program.

Prior to training, GLUT4 protein content was similar in

individuals with NIDDM and controls. Nonetheless, GLUT4 content increased in
all individuals after training. The authors concluded that the antidiabetogenic effects
associated with training were partially due to the increase in muscle GLUT4 protein
content. Similarly, Houmard et al. (1991) investigated the effect of exercise training
on skeletal muscle glucose transporter (GLUT4) levels. Muscle GLUT4 and oral
glucose tolerance test (OGTI) responses were obtained in trained and sedentary
middle-aged men. Plasma insulin levels during the OGTI were significantly lower
in the trained men, whereas no differences were seen in the plasma glucose
responses. GLUT4 protein content was approximately twofold higher in the trained
men. Accordingly, GLUT4 levels appear to be increased in conjunction with insulin
sensitivity in chronically exercise-trained middle-aged men. In a subsequent study
Houmard et al. (1993) investigated the effect of exercise training on GLUT4 protein
concentration in previously sedentary middle-aged men. In this study GLUT4
concentration was assessed before and after 14 weeks of exercise training. The
investigators also examined muscle fiber-type composition. As speculated, the
GLUT4 concentration increased by approximately 1.8-fold.

Moreover, as the

GLUT4 protein increased, the · percentage of GLUT4 rich type Ila muscle fibers
increased by 10%. Therefore, it appears that the concentration of GLUT4 is, in part,
inherent to the muscle fiber-type and as the fiber-type is modified, so is the
concentration of GLUT4.
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On the other hand, in a group of athletes, Andersen et al. (1993) examined
the importance of GLUT4 mRNA, GLUT4 protein and fiber type composition of
skeletal muscle. A biopsy of the vastus lateralis muscle was used to determine fiber
type and GLUT4 concentrations, while the euglycemic hyperinsulinemic clamp was
used to assess insulin-stimulated glucose uptake. The authors concluded that the
abundance of GLUT4 protein and mRNA is increased in skeletal muscle from
endurance trained subjects compared to sedentary subjects. However, it appeared
that GLUT4 protein concentration was not the determinant for the increased insulin
stimulated whole body glucose uptake in endurance trained subjects.
The interaction of exercise training and glucose transport and/or GLUT4 have
been investigated extensively in animal models. For example, Hirshman et al. (1993)
examined the abundance and subcellular distribution of GLUTl and GLUT4 in basal
· and. insulin-stimulated adipose cells from wheel cage exercise-trained rats. Exercise
training increased total GLUT4 by 31% compared with controls. In conclusion
exercise training increased the total amount of GLUT4 protein in

adipose cells.

Further, the increased rate of insulin-stimulated glucose transport in adipose cells
from exercise training is due to the translocation of GLUT4 to the plasma membrane
from an enlarged intracellular pool.
The relationship between insulin induced and exercise induced glucose
transport has been investigated. Nesher et al. (1985) examined the effects of insulin
and contraction on in vitro glucose transport and metabolism in rat epitrochlearis
muscle. It was demonstrated that insulin and contraction activated glucose transport
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and metabolism via independent mechanisms. In addition, the insulin dose�response
curves showed a threshold and saturation-type kinetics, whereas isometric contraction
activated glucose transport and metabolism in a linear fashion with no evidence of
a threshold. Furthermore, the relationships among fiber type, GLUT4 protein
content, and glucose transport activity stimulated maximally with insulin and/or
contractile activity has also been examined (Henriksen et al. 1992).

Insulin

stimulated 2-deoxyglucose (2-DG) uptake was greatest in predominantly type I and
least in predominantly type lib muscle fibers. On the other hand, contractile activity
induced the greatest uptake of 2-DG in predominantly type Ila and least in
predominantly type 11b muscle fibers. The effects of insulin and contractile activity
on 2-DG uptake were additive in all muscle preparations and were greatest in
predominantly type Ila and least in predominantly type lib muscle fibers. In parallei
GLUT4 protein concentrations were greatest in predominantly type Ila and least in
predominantly type 11b muscle fibers. Moreover, linear regression analysis revealed
low if any correlations between GLUT4 protein content and insulin;,.stimulated 2-DG
uptake, but there were significant correlations between GLUT4 protein content and
contractile-stimulated 2-DG uptake. The relationship between GLUT4 protein
content and insulin+ contractile stimulated 2-DG uptake had the strongest (r = 0.992)
correlation. It was concluded that the differences in maximally (insulin+ contractile)
stimulated glucose transport activity among the three fiber types are highly related
to their GLUT4 protein content.
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Ploug et al. (1990) examined the effect of endurance training on glucose
transport capacity and glucose transporter expression in rat skeletal muscle. The
effect of 10 weeks of endurance swim training on 3-0-methylglucose uptake in
skeletal muscle was studied. Training resulted in a 33% increase in maximum
insulin-stimulated glucose uptake in fast-twitch red fibers, and a 33% increase for
contraction-stimulated transport in slow-twitch red fibers compared with non
exercised sedentary muscle. A fully additive effect of insulin and contraction was
observed both in trained and untrained muscle. The mRNA for GLUTl and
GLUT4 increased approximately twofold by training in fast-twitch red muscle fibers.
Parallel to this, Western blot analysis demonstrated an increase in GLUTl and
GLUT4 protein. The authors concluded that the increase in maximum glucose
transport in trained muscle is due to an increased number of glucose transporters.
To elucidate the chronic effect of exercise on GLUT4, Goodyear et al. (1992)
examined glucose transporter number, function, and subcellular distribution in rat
skeletal muscle after exercise training. The authors examined the mechanism of
insulin-stimulated glucose uptake in skeletal muscle by comparing female rats
exercise-trained in a wheelcage for 6 weeks with untrained female rats. The total
number of skeletal muscle plasma membrane glucose transporters, total muscle
homogenate and plasma membrane GLUT4 proteins, and rates of plasma membrane
glucose transport were higher in exercise-trained rats immediately after exercise
training and did not decrease significantly during the five days after cessation of
training. On the other hand, exercise training did not alter microsomal membrane
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total glucose transporter number or GLUT4 protein. GLUTl protein in total muscle
was unaffected by exercise. Consequently, the increased rates of glucose uptake in
endurance-trained skeletal muscle appeared to result primarily from an increased
number and not an increase in the average functional activity of glucose transporters
present in the plasma membrane. Furthermore, these increases persisted for several
days after cessation of exercise training. The specific increase in the GLUT4, but not
the GLUTl glucose transporter isoform, in response to training demonstrates that
a common, chronic physiological stimulus can regulate the expression of the two
glucose transporter isoforms present in skeletal muscle tissue differentially.
To determine the latent effect of exercise on insulin's action, Douen et al.
(1990) investigated the effect of exercise on the recruitment of the insulin-responsive
glucose transporter (GLUT4). The investigators examined the distribution of the
muscle glucose transporters GLUTl and GLUT4 in plasma membrane and
intracellular membrane fractions of skeletal muscle preparations from control,
exercised, and acutely insulin-treated rats. Acute insulin treatment increased GLUT4
transporters in the plasma membrane fraction and decreased GLUT4 transporters
in the intracellular membrane fraction.

Exercise also increased the GLUT4

transporters in the plasma membrane fraction, but in contrast to insulin, did not
significantly decrease GLUT4 transporters in the intracellular fraction. Neither
insulin nor exercise increased GLUTl transporters in the plasma membrane fraction.
The investigators concluded that exercise-sensitive GLUT4 transporters do not
originate from the insulin-sensitive intracellular membrane fraction, suggesting the
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existence of distinct intracellular insulin and exercise-recruitable GLUT4 transporter
pools.
Marette et al. (1992) investigated the abundance, localization, and insulin
induced translocation of glucose transporters in red and white muscle. Glucose
transporter number was twofold higher in isolated plasma membranes of red than of
white muscle. In contrast, the number of transporters in an isolated insulin-sensitive
intracellular membrane organelle was similar in the two muscle groups. The Slow
twitch oxidative (ST) and Fast twitch oxidative-glycolytic (Fr.) fibers demonstrated
an increased number of GLUT4 protein compared with the fast twitch glycolytic
(Frb) fibers. GLUTl activity was restricted to the surface of the muscle cell. Insulin
increased the membrane distribution of GLUT4 protein and glucose transport activity
in red and white muscle. In contrast, insulin did not change the membrane
distribution of GLUTl in red and white skeletal muscle. The molar ratio of GLUT4
to GLUTl in red and white muscle plasma membranes was found to be 4: 1 in the
basal state and 7:1 in the insulin-stimulated state. The researchers concluded that
red muscle contains a higher amount of GLUTl and GLUT4 transporters at the
plasma membrane than white muscle in the basal and insulin-stimulated states but
that GLUT4 translocation does not differ between muscle types. In addition,
GLUT4 expression correlates with the metabolic nature (oxidative vs. glycolytic) of
skeletal muscle fibers rather than with their contractile properties (slow twitch vs. fast
twitch). Similarly, Megeney et al. (1993) examined glucose uptake and GLUT4 in
oxidative and glycolytic rat muscle. In the perfused rat hindlimb muscles the
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proportion of oxidative fibers was highly correlated with the muscle's insulin
stimulated 3-0-MG uptake and GLUT4 content. Insulin-stimulated 3-0-MG uptake
and GLUT4 were also highly correlated. In 3-day denervated muscles, insulin
stimulated 3-0-MG uptake and GLUT4 content was reduced in almost all muscles.
A very high correlation was observed between the decrements in GLUT4 and the
decrements in 3-0-MG uptake. In conclusion, it was demonstrated that glucose
uptake and GLUT4 are regulated by insulin-independent means, namely the
oxidative capacity of the muscle and the normal activity level of the muscle.
On the other hand, Neufer et al.(1992) investigated the effects of training and
detraining on skeletal muscle glucose transporter GLUT4 content in rats. After 1
day or 1 week there was no change in muscle GLUT4 content. Although 6 weeks
of training increased GLUT4 protein content approximately 1.5 fold over controls in
the soleus and red vastus lateralis, whereas no significant change was evident in the
�bite vastus lateralis muscle. GLUT4 protein content returned to near control
values after 1 week of detraining. In parallel, citrate synthase activity showed similar
responses to training and detraining. The authors suggested that expression of
GLUT4 protein is coordinated with the well-documented. adaptations in oxidative
enzyme activity with endurance training and detraioing.
To determine if a decrease in GLUT4 was an aging phenomena, Kem et al.
(1992) investigated the effect of aging and exercise on GLUT4 protein in skeletal
muscle. This study focused on the relationship between muscle GLUT4 protein and
aging induced deterioration in glucose tolerance. Furthermore, it investigated
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whether exercise training would increase GLUT4 protein levels in older animals.
Exercise training produced a significant increase in GLUT4 protein in the soleus and
gastrocnemius muscle of young and middle-aged rats compared with sedentary
controls. In the oldest rats, GLUT4 was not significantly increased with training, but
a trend ·toward an increase was apparent. The main effect of aging was primarily due
to a statistically significant difference between the old trained and young trained rats.
The training program increased the old trained GLUT4 content to equal that of the
middle-aged untrained animals.
The effects of exercise on insulin resistance in the obese Zucker rat have been
examined. Friedman et al. (1990) studied the effect of exercise training on glucose
transporter protein GLUT4 in skeletal muscle of obese Zucker rats. The authors
examined the level of GLUT4 protein in the gastrocnemius muscle of 36 week old
genetically obese Zucker rats and their lean littermates, and in obese Zucker rats
following 18 or 30 weeks of treadmill exercise training. The level of GLUT4 protein
was similar in the lean and insulin-resistant obese Zucker rats. Exercise training the
obese Zucker rats increased GLUT4 protein levels 2. 3 fold above sedentary obese
Zucker rats. The authors suggest that endurance training stimulates expression of
skeletal muscle GLUT4 protein which may be responsible for the previously observed
increase in insulin sensitivity with training. Consequently, Brozinick et al. (1992)
examined the rates of muscle glucose uptake of lean and obese Zucker rats under
basal conditions, maximally stimulating concentrations of insulin and muscle
contraction elicited by electrical stimulation of the sciatic nerve. Basal glucose
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uptake was similar for lean and obese rats, although plasma membranes from lean
rats contained 82% more GLUT4 protein than obese rats. Insulin stimulation
resulted in a significant increase in plasma membrane GLUT4 protein concentration
in lean but not obese rats. Glucose uptake of lean rats in the presence of insulin was
approximately fourfold greater than that of obese rats. Moreover, this difference in
glucose uptake could not be completely accounted for by the difference in plasma
membrane GLUT4 concentrations. Stimulation by contraction resulted in similar
increases in plasma membrane GLUT4 concentration and glucose uptake rates in
both lean and obese rats. It was concluded that muscle insulin resistance in the
obese Zucker rat is due to a decrease in GLUT4 translocation and activity.
However, contraction stimulated glucose uptake and GLUT4 protein translocation
and activation are normal in the obese Zucker rat. In a subsequent study Brozinick
et al. ( 1993) examined the rate of skeletal muscle glucose uptake in trained and
untrained obese Zucker rats under basal, insulin stimulated and contractile
conditions. · In this study it was demonstrated that exercise training did not alter
basal, insulin-, or contraction-stimulated GLUT4 . functional activity. Furthermore,
aerobic exercise increased insulin- and contraction-stimulated muscle glucose uptake
via increased plasma membrane GLUT4 protein concentration and not an increased
GLUT4 protein translocation or functional activity.
Subsequently, the effects of muscle activity and fiber composition on glucose
transport and GLUT4 were examined. To elucidate the effects of exercise training
intensity on insulin-stimulated 3-0-MG transport and GLUT4 protein, Banlcs et al.
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(1992) examined red and white quadriceps of high and low intensity exercised trained
obese Zucker rat. Sedentary obese and lean Zucker rats were used as controls.
Although, no differences existed between red quadriceps of high and low intensity
trained rats, training in general increased both 3-0-MG transport and GLUT4
protein concentrations over sedentary obese rats. In the white quadriceps 3-0-MG
transport between high and low intensity . trained rats approached significance
(p < 0.07). GLUT4 protein concentrations and citrate synthase activity of high
intensity trained rats were significantly greater than sedentary obese rats. The
authors concluded that the improvement in muscle insulin resistance of the obese
Zucker rat after exercise training is due in part to an increased GLUT4
concentration, which is related with the degree to which the muscle is trained.
In conclusion, the decrease in insulin-stimulated glucose transport associated
with insulin resistant states is in part due to a reduction in the compartmentalization,
activity and/or translocation of GLUT4 protein. It appears that not all models of
insulin resistance exhibit a decrease in total GLUT4 protein (NIDDM and the
Zucker obese rat). Moreover, compartmentalization, activation and translocation
appears to be aberrant in the Zucker obese rat. Nonetheless, it is apparent that
physical activity can have a significant affect on the glucose transport system. It has
been demonstrated that training, detraining and age influence the capacity of the
glucose transport system and GLUT4 protein levels. Furthermore, exercise can
increase glucose transport to the same level as a maximum dose of insulin.
Although, it appears that insulin resistance is associated with the insulin-induced
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glucose transport system and not the contractile-induced glucose transport system.
The mechanisms that elicit the insulin and contractile responses appear to have an
additive effect and tissue GLUT4 protein has it's highest correlation with
insulin+ contractile-stimulated glucose transport. Further, increasing the plasma .
membrane GLUT4 protein via exercise training also enhances insulin-stimulated
glucose transport. Regular exercise training also increases insulin sensitivity for
several days after the final bout of exercise. Thus, exercise appears to increase the
number (especially in the plasma membrane) and/ or the translocation/ activation of
the insulin-responsive glucose transporter protein GLUT4. In addition, physical
inactivity bas been shown to elicit an insulin resistant state and a decrease in
GLUT4. Therefore, it appears that exercise training has a positive and predictable
effect on glucose transport and GLUT4 protein.

Recently, it has been demonstrated that dietary manipulation has the
potential to modify peripheral insulin sensitivity (Kahn and Pedersen 1993). Rats
that are obese from high fat feedings have a suppression of GLUT4 expression in
skeletal muscle and fat cells (Kahn and Pedersen 1993 and Pedersen et .al. 1991).
Similarly, it has been· demonstrated that a high sodium intake has the potential to
exacerbate insulin resistance (Donovan et al. 1993). Hence, a growing body of
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research has focused on manipulating fat, complex carbohydrate, sucrose, and other
nutrients in the diet to elucidate their effects on peripheral insulin sensitivity.
For example, Barnard et al. (1993) examined the effects of a high-fat-sucrose
diet on serum insulin and related syndrome X associated atherosclerotic risk factors
in rats. Fischer 344 rats were fed a high-fat-sucrose diet or low-fat, high-complex
carbohydrate diet for 2 years.

The high-fat-sucrose diet rats were obese,

hypertensive, hyperinsulinemic, and hypertriglyceridemic.

Furthermore, they

exhibited enhanced clotting and impaired fibrinolytic response to streptokinase.
Insulin was positively correlated with body weight, triglycerides, and systolic blood
pressure. Total cholesterol and HDL-cholesterol were unchanged. Hence, the
authors concluded that many syndrome X associated risk factors can be induced with
high-fat-sucrose diets. The aggregation of risk factors for atherosclerosis was found
in the high-fat-sucrose diet rats and not the low-fat, high-complex-carbohydrate diet
animals. In fact, most of the rats on the low-fat, high-complex-carbohydrate diet
developed no risk factors after 2 years, indicating that the development of risk factors
is not an aging phenomenon. Consequently, Barnard et al. (1994) examined the
reversibility of the diet-induced skeletal muscle insulin resistance.

They

demonstrated that 8 weeks on a high-fat-sucrose diet did not change the number of
insulin receptors assessed by usl-insulin binding.

However, maximum insulin

stimulated glucose transport and maximum insulin-stimulated receptor tyrosine kinase
activity were significantly decreased but could be restored with 4 weeks of low-fat,
high-complex-carbohydrate diet.
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It appears that obesity alone has a profound effect on glucose transport.
Elton et al. ( 1994) investigated the relationship between glucose transport and body
mass index using muscle biopsies from 30 females (BMI from 16-40). There was a
significant negative relationship between stimulation of glucose transport and BMI.
There was a continuous decline in glucose transport at BMI's greater then 30 kg/m2•
However, the decrease in glucose transport associated with obesity was ameliorated
with weight loss.

Friedman et al. (1992) demonstrated with the euglycemic

hyperinsulinemic clamp that weight loss via gastric bypass in obese patients could
partially restore blunted glucose transport. Although, impaired in vivo glucose
transport was partially restored in these patients with weight loss, weight loss elicited
no change in vastus lateralis GLUT4 protein concentration. The authors suggested
that skeletal muscle insulin resistance in morbid obesity is reversible with weight loss
and is associated with enhanced transporter translocation and/ or activation but not
an increase in GLUT4 protein.
Peripheral insulin resistance can also be modified by dietary manipulation.
Grimditch et al. (1988) demonstrated in Sprague-Dawley rats that the presence of
sucrose and/or the absence of complex carbohydrates, not high fat, was responsible
for the insulin resistance and it was not improved by adding fiber to the diet or by
exercise training.
A high-fat diet with or without exercise can have a significant impact on
glucose transport and GLUT4 protein. Rosholt et al. (1994) examined the effect of
insulin and exercise on male Sprague-Dawley rats fed a high-fat or high-carbohydrate
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diet. It was demonstrated that maximal glucose transport increased three-fold with
insulin treatment or acute exercise training compared to the treatment free controls
in the high-carbohydrate diet rats. In the high-fat animals the glucose transport
increases were less than twofold.

In contrast to findings from Grimditch et al.

( 1988), the high-fat diet animals exhibited resistance to both exercise and insulin
stimulation of muscle glucose transport. Similarly, Pedersen et al. (1991) examined
the effect of high-fat fceding, overfeeding, or energy-restriction on insulin resistance
and the expression of GLUT4 in fat cells of Sprague-Dawley rats. High-fat feeding
was associated with relative postprandial hypoglycemia and hypoinsulinemia. The
high-fat fed animals had decreased body weight but increased adiposity as
demonstrated by epididymal fat pad weight. Fat feeding caused a 78% reduction in
insulin-stimulated glucose transport per adipocyte. In addition there was a 92-94%
reduction in GLUT4 mRNA and protein per adipocyte in fat-fed rats. Even though
energy restriction and overfeeding elicited opposite changes in adiposity, no changes
occurred in glucose transport or GLUT4. Thus, the impaired insulin-stimulated
glucose transport in adipose cells from high fat-fed rats occurs in the presence of a
dramatic decrease in the expression of GLUT4. Moreover, it was speculated that the
reduced gene expression may be caused by chronic hypoinsulinemia and may
contribute to the insulin resistance observed in this state. Consequently, Kahn et al.
( 1993) demonstrated that obesity due to high fat feeding, but not due to high
calorie/carbohydrate feeding or genetics, is associated with pretranslational
suppression of GLUT4 expression in skeletal muscle.
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The authors went on to

conclude that in at least some forms of obesity, the level of GLUT4 expression in
muscle appears to be only one factor in, or may .even be unrelated to, the degree of
insulin-responsive glucose transport in vivo. In contrast, Okamoto et al. (1992)
demonstrated that insulin resistance in rats fed a high-fat diet exhibit a post-receptor
defect in muscle, although tyrosine-phosphorylation of both insulin receptor and its
endogenous substrate are decreased in liver. Moreover, levels of both GLUT4 from
muscle and GLUT2 from liver in the crude membrane were comparable to those of
the controls. Penicaud et al. (1991) demonstrated an enhanced expression of GLUT4
in white adipose tissue of young obese fa/fa rats subjected to a high fat diet upon
weaning. These data indicated the existence of an enhanced expression of GLUT4
in white adipose tissue of young obese rats which could be related to an increased
plasma insulin level.
Specific fatty acids have unique effects on insulin sensitivity. Hunnicutt et al.
(1994) demonstrated that saturated fatty acids induce insulin resistance in rat
adipocytes. These investigators demonstrated that saturated fatty acids stimulate
glucose transport acutely, but on prolonged exposure induce insulin resistance via a
post-insulin binding defect. It has also been demonstrated that dietary fish oil
decreases the sensitivity of glucose uptake to insulin in isolated rat adipocytes
(Macho et al. 1993). Furthermore, arachidonic acid has been shown to down
regulate the insulin-dependent glucose transporter gene (GLUT4) in adipocytes by
inhibiting transcription and enhancing mRNA turnover (Tebbey et al. 1994).
Kaufman ·et al. (1994) fed male Sprague-Dawley rats a diet high in either saturated
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fat or polyunsaturated fat beginning at 10 weeks of age. After 10 weeks of diet
treatment, blood pressure was 17% higher in rats fed saturated fat and 8% higher
in rats fed polyunsaturated fat than in rats fed a low-fat control diet. Moreover, rats
fed the saturated fat diet became obese, and their fasting insulin levels were elevated
(38% above control).

The authors concluded that both saturated and

polyunsaturated dietary fats induce hypertension. Findings from our work (Abel et
al. 1995) indicate that feeding lean animals a high fat diet unmasked heterogeneity
in mean arterial blood pressure, plasma insulin and glucose, and energy efficiency.
The variability in mean arterial blood pressure was correlated with blood glucose and
energy efficiency in high fat fed rats. Lean animals fed a high fat diet with the
highest mean arterial blood pressures also had higher circulating insulin and glucose
as well as a higher energy efficiency ratio. The ability of a high fat diet to raise
mean arterial blood pressure was related to the ability of a high fat diet to exert a
diabetogenic effect and possibly promote fat storage.
Further, Ivy et al. (1986) demonstrated that a high carbohydrate diet and
exercise training increased the rate of glucose uptake in the obese Zucker rat. More
importantly, the combined effect of diet and exercise training was greater than the
sum of their individual effects. It appears that the effect of diet and exercise is
synergistic in reducing the muscle insulin resistance in the obese Zucker rat.
Moreover, Sherman et al. (1993) found that hyperglycemia associated with
pancreatectomized lean and obese Zucker rats may be an important factor in the
reduction of muscle GLUT4 levels in lean and obese rats. The reduced GLUT4 was
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accompanied by reduced maximal glucose transport in lean but not obese rats.
Notably, exercise training reduced hyperglycemia, normalized glucose transport, and
increased muscle GLUT4 in obese animals. Thus, the beneficial effects of exercise
training resulted in a reduction in hyperglycemia and chronic adaptions in skeletal
muscle glucose transport capacity including increased GLUT4. It also appears that
carbohydrate metabolism may alter insulin resistance in the obese Zucker rat. Ivy
et al. (1994) demonstrated that pair-feeding for 3 weeks with 6 energy % calcium
pyruvate or pyruvylglycine resulted in: decreased weight gain; lower food conversion
efficiency; and higher resting oxygen consumption than control rats. The experimental
diets also resulted in increased lipid oxidation and decreased carbohydrate oxidation.
Moreover, the pyruvylglycine rats had a lower insulin response despite their elevated
plasma triglyceride concentrations. Thus, it appears that both experimental diets
favorably alter the metabolism of the obese Zucker rats. In addition, pyruvylglycine
reduces the insulin resistance that develops spontaneously in the obese rats.
The mechanism of fatty acid-induced inhibition of glucose uptake has been
investigated. It has been demonstrated that glucocorticoid-induced muscle insulin
resistance is due to excessive non-esterified fatty acid oxidation. The proposed
mechanisms of this insulin resistance was that increased fatty-acid oxidation
ultimately inhibited glucose transport, or decreased glycogen synthesis, or directly
affected glucose transport translocation and/or activity (Guillaume et al. 1993). In
parallel, Boden et al. (1994) examined the mechanisms of fatty acid-induced
inhibition of glucose uptake. The authors investigated the effects of three steady
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state plasma free fatty acid levels on rates of glucose uptake, glycolysis, glycogen
synthesis, carbohydrate oxidation, hepatic glucose output, and nonoxidative glycolysis
during euglycemic-hyperinsulinemic clamp. Increased free fatty acid concentrations
decreased glucose uptake in a dose-dependent fashion. The decrease was caused
mainly by a reduction in glycogen synthesis and to a lesser extent by a reduction in
carbohydrate oxidation. At high free fatty acid infusion there was an impaired
glycogen synthesis activity in muscle, associated with an increase in glucose-6phosphate concentration, which developed after 4-6 hours of fat infusion. At medium
free fatty acid concentrations there was a decrease in muscle glucose-6-phosphate
concentration, which may have been the consequence of reduced glucose
transport/phosphorylation. In addition, free fatty acids and/or glycerol increased
insulin-suppressed hepatic glucose output. It was concluded that free fatty acids
cause a dose-dependent inhibition of insulin-stimulated glucose uptake and that free
fatty acids and/or glycerol increase insulin-suppressed hepatic glucose output and
thus caused insulin resistance at the peripheral and the hepatic level.
' .

In summary, skeletal muscle insulin resistance appears to be the hallmark of
syndrome X. The decrease in insulin-stimulated glucose transport associated with
insulin resistant states is in part due to a reduction in the activity, translocation
and/or compartmentalization of GLUT4 protein. It is apparent that physical activity
and dietary modification can have a significant effect on the glucose transport system.
Furthermore, environmental manipulation of insulin sensitivity has been documented
in several models of insulin-resistance. Exercise can increase glucose transport to the
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same level as a maximum dose of insulin. The mechanism that elicits this response
has an additive effect when coupled with insulin, but it also enhances the activity of
the insulin-stimulated response. Regular exercise training also increases insulin
sensitivity for several days after the final bout of exercise. Chronic exercise appears
to increase the number and/or the translocation/activation of the insulin-responsive
glucose transporter protein GLUT4. In addition, physical inactivity has been shown
to elicit an insulin resistant state and decrease GLUT4 protein. Thus, exercise
training has a positive and predictable effect on glucose transport and GLUT4
protein. On the other hand, the effect of various dietary constituents on insulin
sensitivity are not as predictable as manipulating activity. Moreover, it appears that
there may be diet-gene interactions adding to the unpredictability of dietary
modification in various models of insulin resistance.
In conclusion, there has been tremendous progress made in understanding the
complex relationship between insulin resistance, glucose transport, and environmental
influences, but there are still many important unanswered questions. There are
numerous studies examining the effect of exercise training on the glucose transport
system, but few studies have addressed dietary influences on this system. Moreover,
· there appears to be relatively few studies that investigate the possibility of gene-diet
interactions influencing the aberrations associated with syndrome X. Indeed, insulin
resistance is the hallmark of many chronic diseases that plague our society today.
Therefore, it is important to understanding the interaction of genetics and
environment in insulin resistance.
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PART III.

INSULIN REGULATION OF VASCULAR SMOOTH MUSCLE GLUCOSE
TRANSPORT IN INSULIN-SENSITIVE AND RESISTANT RATS

ABSTRACT
Previous studies from this laboratory have demonstrated insulin regulation of vascular
smooth muscle intracellular calcium transport and of vascular tone. Accordingly, we
measured insulin regulated glucose transport and GLUT4 protein in aortic tissue
from insulin-resistant and sensitive rats in order to document classical insulin action
in this tissue. We assessed, via in

vitro

muscle-bath and perfusion; and via in vivo

infusion, basal and insulin-stimulated (3H]-2-deoxyglucose transport in aorta from
lean and obese Zucker rats.

In the muscle-bath system, insulin significantly

stimulated aortic 2-deoxyglucose transport by 30%, but there was no difference in
either baseline or insulin-stimulated glucose transport in lean versus obese rats.
However, in the perfusion system, in which only the luminal surface of the vessel was
e lxosed, insulin significantly (p < 0.04) stimulated 2-deoxyglucose transport in the
aorta of only the lean animals. Western blot analysis demonstrated that aortlxfrom
lean and obese Zucker rats contained substantial concentrations of GLUT4 protein.
Surprisingly, in the muscle-bath system 2-deoxyglucose transport was markedly higher
in the aorta than in the soleus (p < 0.0002). These data demonstrate that vascular
smooth muscle is an insulin-sensitive tissue which appears to be partially impaired
in the insulin-resistant animals.
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INTRODUCTION

The obese Zucker rat (fa/fa), a well characterized and widely used rat model
of genetic obesity (Cortez et al. 1991, Ivy et al. 1989, Sherman et al.1988), exhibits
chronic skeletal muscle insulin resistance. These animals exhibit obesity and
hyperinsulinemia by 4-5 weeks of age (Bray 1977, Fletcher et al.1986, Ionescu et al.
1985, Kasiske et al. 1985, Martin and Gahagan 1977, Stem et al. 1975, Zucker and
Antoniades 1972), and insulin resistance is evident by 11-13 weeks of age (Ionescu
et al. 1985). The obese Zucker rat is also an established model of hypertension, with
significant elevations in systolic and. diastolic blood pressure evident as early as six
weeks of age (Kurtz et al. 1989, Shehin et al. 1989, Yoshioka et al. 1993, Zemel et
al. 1990a and 1990b, Zemel et al. 1992).
Traditionally, insulin resistance has been considered pathway specific
. (primarily involving glucose transport and metabolism) and tissue specific (primarily
affecting skeletal muscle, adipose, and liver) (Castillo et al., DeFronzo et al. 1983,
Ferrannini et al. 1987, Rocchini 1991, Zemel et al. 1992). However, recent data
suggest there are other "non-classical" insulin sensitive pathways such as calcium
metabolism and tissues including vascular smooth muscle which are affected in
insulin resistance (Abel and Zemel 1993b, Kim and Zemel 1993, Zemel et al. 1992,
Zemel et al. 1991, Zemel et al. 1990a and 1990b).
The demonstrated elevations in blood pressure accompanying insulin resistant
states have been attributed to a lack of feedback inhibition for insulin release,
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resulting in hyperinsulinemia and consequent increases in sympathetic output (Hall
et al. 1989). However, recent evidence, from our laboratory and others, indicates
that insulin exerts a direct vasodilatory effect on the vasculature, and this effect is
impaired in insulin resistant states (Abel and Zemel 1993b, Shehin et al. 1989, Zemel
et al. 1991, Zemel et al. 1990a and 1990b). Insulin accelerates the rate of vascular
smooth muscle recovery from pressor agonist-induced intracellular free calcium
transients, while these recovery rates are blunted in both insulin resistant and
insulinopenic rats (Abel and Zemel 1993a and 1993b, Kim and Zemel 1993).
Similarly, insulin attenuates vascular reactivity responses to pressor agonists, as both
insulin resistant and insulinopenic animals exhibit exaggerated vascular reactivity
(Reddy et al. 1990, Zemel et al. 1990a). Further, we have recently found these
effects to be dependent, in part, upon glucose transport and metabolism (unpublished
data). Accordingly, the purpose of this study was to determine if insulin stimulates
glucose transport in aortic tissue and if so, determine whether aortic tissue glucose
transport is impaired in insulin resistant states.
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MATERIALS AND METHODS

Housing and care of animals

Lean (Fa/?) and obese (fa/fa) Zucker rats were purchased from Charles
River Inc. (Wilmington, MA) or generated from our breeding colony (parent animals
from an established vendor). Upon arrival the rats were housed 2/cage and provided
food (Agway Prolab Rat Mouse Hamster 3000, Syracuse, NY) and water ad libitum.
A temperature of 21°C and an artificial 12-h light-dark cycle were maintained in the
animal room. This study was approved by the Institutional Animal Care and Use
Committee of the University of Tennessee.
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Muscle-bath system with 2-deoxyglucose

Glucose transport activity was measured by using the nonmetabolizable
glucose analogue [3H]-2-deoxyglucose and a modified in vitro muscle-bath procedure
previously used in rat skeletal muscle (Karlstad and Sayeed 1986, Youn et al. 1991,
Young et al. 1986). Food was withheld overnight, 4 lean and 4 obese animals (20
weeks of age) were then anesthetized with 50 mg/kg sodium pentobarbital and soleus
and thoracic aorta were carefully removed and cleaned in ice-cold Krebs-Henseleit
buffer (Karlstad and Sayeed 1986). The rat hindlimb contains tissue that exhibits the
three types of skeletal muscle fibers (Armstrong and Phelps 1984): slow twitch, fast
twitch a , and fast twitch b· The soleus muscle contains predominantly (89%) slow
twitch muscle fibers, which have been demonstrated to be extremely insulin sensitive
(Cortez et al. 1991, Ivy et al. 1989). Thus, the soleus muscle has been established as
an insulin sensitive tissue, which exhibits insulin resistance in the obese Zucker rat
(Sherman et al. 1988, Zucker and Antoniades 1972). The aorta was sectioned into
4 similar pieces and the soleus was gently split and mounted on small wires to resting
length with each animal serving as its own control. After a 30 minute incubation in
oxygenated Krebs-Henseleit buffer, muscles were transferred to a flask containing
10 ml Krebs-Henseleit buffer (pH 7.4),

32 nmol/L [3H]-2-deoxyglucose (NEN,

Boston, MA) (3.7 kBq), 1.5 umol/L [14C]mannitol (NEN, Boston, MA) (185 Bq) (for
extracellular volume correction), 0.1 % albumin, and 140 nmol/L insulin or acetic
acid control (Karlstad and Sayeed 1986). Incubations 10 minutes aorta and 20

minutes soleus were carried out in a Dubnoff metabolic shaker (Chicago, IL) at 37°
C in an atmosphere of 95 % 02 and 5 % CO2• Following incubation, the muscles were
gently blotted on filter paper and frozen in liquid nitrogen. The samples were then
weighed, dried overnight at 68° C, reweighed and solubilized in 1 ml of Solvable
(NEN, Boston, MA). Ten ml of liquid scintillation fluid (Formula 989 NEN, Boston,
MA) was added to the solubilized samples. Simultaneous determination of 3H and
14

C was used to calculate the amount of 2-Deoxyglucose incorporated into tissues in

the presence or absence of insulin.
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Perfusion system with 2-deoxyglucose

Glucose transport activity was measured using an in vitro perfusion procedure
in isolated, intact aorta. Food was withheld overnight, 6 lean and 6 obese animals
(25 weeks of age) were then anesthetized with sodium pentobarbital and aorta were
carefully removed, sectioned (each animal served as its own control), and cleaned in
ice-cold Krebs-Henseleit buffer. Sections of aorta were attached to a syringe
mounted on an infusion pump (Harvard Apparatus Pump 22, Southnatick, MA) and
perfused with 5 ml (0.5 ml/min) of oxygenated Krebs-Henseleit buffer (pH 7.4)
containing 32 nmol/L [3H]-2-deoxyglucose, (3.7 kBq), 1.5 umol/L [14C]mannitol (185
Bq) and 0.1 % albumin, with or without 140 nmol/L insulin. Following perfusion, the
aorta were gently blotted on filter paper and weighed. The samples were then dried
in a vacuum oven at 900 C, reweighed and solubilized in 1 ml of Solvable. Ten ml
of liquid scintillation fluid was added to the solubilized samples. Simultaneous
determination of 3H and 14C was used to calculate the amount of 2-deoxyglucose ·
incorporated into tissues in the presence or absence of insulin.
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Infusion system with 2-deoxyglucose

Glucose transport activity was measured using a modification of an in vivo
infusion procedure previously used in rat skeletal muscle (Turinsky 1987). Food was
withheld overnight, 8 lean and 8 obese animaJs (25-30 weeks of age) were then
anesthetized with sodium pentobarbital (50 mg/kg body wt) and injected
intravenously (penile vein) with a bolus dose of 32 nmol/L (3H]-2-deoxyglucose, (3.7
kBq), 1.5 umol/L (14C]mannitol (185 Bq) and 0.1% albumin, with or without 140
nmol/L insulin. Following a 10 minute infusion, the aorta and soleus were removed
and weighed. The samples were then dried in a vacuum oven at 900 C, reweighed
and solubilized in 1 ml of Solvable. Ten ml of liquid scintillation fluid was added to
the solubilized samples. Simultaneous determination of 3H and 14C was used to
calculate the amount of 2-deoxyglucose incorporated into tissues in the presence or
absence of insulin.
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Determination of GLUT4 Protein

Thoracic aorta and soleus were removed from 4 lean and 4 obese Zucker rats
(17-20 weeks of age), washed in ice-cold phosphate-buffered saline, minced and
dissolved in suspension and gel loading buffers (Sambrook et al. 1989). Following
ten minutes of boiling, the preparation was sonicated, centrifuged and the
supernatant was removed. Proteins (200 µg) were separated by 10% SDS-PAGE
Tris-glycine and electroblotted and/or immobilized on PVDF membrane for
immunoblot analysis.

125

1-Protein A (NEN, Boston, MA) and. anti-rabbit polyclonal

antibody to GLUT4 protein (gift from Dr. Cushman) were used to determine
GLUT4 concentrations. Aortic tissue GLUT4 protein was also demonstrated via
BioRad (Hercules, CA) Immuno-lite kit for chemiluminescent determination of
proteins in conjunction with Genzyme (Cambridge, MA) mouse-anti-rat monoclonal
antibody to GLUT4 protein. Blots were exposed to several films for 2-4 days and
densitometry was performed to determine relative concentrations of tissue GLUT4
protein.
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Statistical Considerations

These studies used a completely randomized design with two treatments (basal
and maximal insulin-stimulated glucose transport) and two levels (lean and obese
Zucker rats). Two-way analysis of variance was used to determine statistical
significance of the main effects. Comparisons between aorta and soleus in each
transport assay system were evaluated via t-tests and significance was confirmed at
(p < 0.05). All values are reported as means ± standard error.
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RESULTS
In the muscle-bath system, insulin stimulated aortic 2-deoxyglucose transport
by 30% (Figure ill. ta, Table m. t), but there was no difference in either baseline or
insulin-stimulated glucose transport in lean versus obese Zucker rats. Moreover, in
the perfusion system insulin significantly (p < 0.04) stimulated 2-deoxyglucose
transport in the aorta of the lean, but not in the aorta of the obese Zucker rats
(Figure lb). Not surprisingly, there appeared to be a trend toward reduced baseline
transport in the aorta of the obese versus lean Zucker rats (Figure III.lb), although
this difference was not statistically significant (p < 0.07). In contrast, in the in vivo
infusion system, insulin failed to elicit stimulation of 2-deoxyglucose transport in the
aorta of lean Zucker rats. The lack of insulin stimulation in the aortic infusion
system resulted from several limitations of the technique. Nonetheless, western blot
analysis demonstrated that aorta contained substantial concentrations of GLUT4
protein, with no significant difference between lean and obese animals (Figure 111.2).
As expected in the muscle-bath system, both baseline (p < 0.03) and insulin
stimulated (p < 0.004) 2-deoxyglucose transport in soleus were lower in obese than
in lean rats. Although these findings do not parallel the findings in the aorta, they
are consistent with the previous literature on this topic (Cortez et al. 1991, Ivy et al.
1989, Sherman et al. 1988). In the infusion system, insulin significantly (p < 0.02)
stimulated 2-deoxyglucose transport in the soleus of all animals. Paradoxically,
western blot analysis demonstrated that obese rat soleus contained substantial
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(p < 0.01) higher concentrations of GLUT4 protein then there lean littermates
(Figure 111. 2).
Surprisingly, in the muscle-bath system, basal and insulin stimulated 2deoxyglucose transport were markedly higher in the aorta than in the soleus ( 123 %,
p < 0.0002) of lean and obese animals (Figure 111. 3). Similarly, in the in vivo infusion
system the rate of basal and insulin stimulated 2-deoxyglucose transport in aorta was
265 % (p < 0.02) greater then basal 2-deoxyglucose transport in soleus.
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Table m.t: 2-dco.xyglucosc transport in solcus and/or aorta of lean and/or obese rats.

group

basal (nM/min/g) insulin-stimulated

MUSCLE-BATH

± 0.1

*#

lean soleus

1.8 ± 0.2

2.2

lean aorta

14.1 ± 0.7

18.3 ± 1.0

*s

obese soleus

1.1 ± 0.3

1.4 ± 0.3

*

obese aorta

14.2 ± 0.8

18.2 ± 0.9

*s

lean aorta

8.41 ± 2.06

135 ± 1.87

*

obese aorta

5.3 ± 0.65

8.2 .±. 3.64

lean soleus

13.0 ± 2.2

2.l.5 .±. 5.0

*

lean aorta

48.9 ± 1 1.2

38.0 ± 12.2

*s

PERFUSION

INFUSION

* p < 0.05 versus. basal
#

p < 0.05 versus obese

s p < 0.05 versus soleus
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*

20

• BASAL
0 lNSULIN

*

15

5

0

Piguft: 111.1

LEAN

OBESE

(a. upper panel) Aortic muscle-bath measurements of basal and insulin stimulated 2-deoxyglucosc transport in

lean and obese Zucker rats. Lean and obese animals exhibited a significant insulin stimulated increase in 2-deoxygtueo&e uptake
(• indicates p < 0.03, n = 4 lean and 4 obese). (b. lower panel) Aortic perfusion measurements of basal and insulin stimulated
2-deoxyglucose transport in lean and obese Zucker rats. Only lean animals cxJubited a significant insulin stimulated increase in
2-deoxyglucose uptake C- indicates p < 0.04, n = 6 lean and 6 obese) (values arc means .±. SEM).
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Insulin stimulated 2-deoxyglucose transport in soleus versus aorta of all (lean and obese) Zucker rats using the

muscle-bath system

c· indicates p < 0.03, n = 4 lean and 4 obese) (values arc means .±. SEM).
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DISCUSSION

We have demonstrated that aortic tissue contains a substantial concentration
of the insulin-stimulated glucose transporter (GLUT4) and exhibits insulin dependent
glucose transport. This is consistent with Cooper et al. (1993), who demonstrated the
presence of GLUT4 protein, GLUT4 mRNA and glucose transport in A-10 vascular
smooth muscle cells. In previous studies, this laboratory has demonstrated the role
of insulin in regulating vascular smooth muscle reactivity and cell calcium regulation
(Abel et al. 1993b, Kim and Zemel 1993, Zemel et al. 1992, Zemel et al. 1991,
Zemel et al. 1990a and 1990b). This regulation is blunted or lost in insulin resistant
states, as these "non-classical" actions of insulin are not well preserved in vascular
smooth muscle of insulin resistant . animals (Abel et al. 1993b, Zemel et al. 1991,
Zemel et al. 1990a and 1990b). Further, we have recently shown these effects to be
glucose dependent,· as inhibition of glucose transport and/or metabolism (with
appropriate replacement of energy substrate) eliminates these effects (unpublished
data). Accordingly, we sought to determine if aortic tissue transports glucose in an
insulin dependent fashion and if so, dete�ne if aortic tissue exhibits resistance to
this action in an insulin-resistant state. If so,. this could explain; in part, -the loss of
the "non-classical" actions of insulin on vascular smooth muscle function. Data from
the present study supports this concept, as insulin perfusion stimulated 2deoxyglucose transport in lean, but not obese Zucker rats.

96

The muscle-bath and perfusion methods elicited significant insulin stimulated
2-deoxyglucose transport in aorta from lean Zucker rats. However, in the muscle
bath system we demonstrated similar basal and insulin stimulated 2-deoxyglucose
transport in aorta from lean and obese Zucker rats (Figure la). In contrast, in the
in vitro perfusion system we demonstrated insulin stimulated 2-deoxyglucose transport

in aorta from only the lean animals. In retrospect, the muscle-bath technique
presents potential limitations. For example, we question the consequence of allowing
insulin and 2-deoxyglucose exposure to all surfaces of the aorta and the possible
removal of the endothelial layer from the aorta during dissection. Consequently, the
perfusion technique appears to be a more accurate portrayal of glucose transport
across the luminal surface of the vessel. Therefore, the perfusion technique may be
the most physiologically pertinent procedure.
The infusion method elicited significant insulin stimulated 2-deoxyglucose
transport in the soleus but not in the aorta. Clearly, 2-deoxyglucose transport is
dependent upon the concentration of labeled 2-deoxyglucose substrate in the media.
However, unlike the in vitro systems, muscle-bath and perfusion, we could not control
the 2-deoxyglucose concentration in the in vivo infusion system. Consequently, in the
infusion system there was a dramatic decrease in blood 2-deoxyglucose and glucose
concentration of the insulin-stimulated group compared to the control group, which
created a distinct discrepancy in the concentration of 2-deoxyglucose that the aortic
tissue was exposed to for the 10 minutes of infusion. This rapid decline in 2deoxyglucose concentration in the insulin stimulated group created an artifact
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rendering the results of the procedure invalid. Several attempts at compensating for
this rapid decline of 2-deoxyglucose in the insulin stimulated animal by simultaneous
infusion of glucose and/or 2-deoxyglucose did not resolve this problem, as skeletal
muscle served as a substantial sink for insulin-stimulated 2-deoxyglucose uptake.
Accordingly, the lack of aortic 2-deoxyglucose transport in vivo may be attributed to
limitations of the infusion technique, hence, the in vivo infusion system does not
appear to be as suitable for assessment of aortic 2-deoxyglucose transport as it is for
skeletal muscle.
Paradoxically, the aorta contained substantially (p < 0.0003) less GLUT4
protein, but transported significantly (p < 0.0002) greater amounts of 2-deoxyglucose
than the soleus. Most likely, this discrepancy is due to the direct relationship
between tissue weight and glucose transport (Crettaz et al. 1980). Alternatively, this
discrepancy could result from a different distribution of glucose transporters
(GLUT4/GLUT1 ratio) present in the aorta relative to soleus transporter
distribution.
Surprisingly, the soleus of the obese animals contained substantially (p < 0.01)
higher concentrations of GLUT4 protein than soleus from lean littennates, but
transported significantly (p < 0.03) less 2-deoxyglucose than the lean animals. There
is an accumulating body of evidence suggesting there is no significant difference of
GLUT4 protein content in normal vs insulin resistant states (Bader et al. 1992,
Brozinick et al. 1991 and 1992, Davidson 1993, Eriksson et al. 1991, Friedman et al.
1992 and 1990, Garvey et al. 1992, Handberg et al. 1990, Pedersen et al. 1990). It
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has also been demonstrated that plasma insulin is positively correlated with glucose
transport and GLUT4 protein concentration (Barnard et al. 1990, Kahn et al. 1987).
Thus, as plasma insulin increases (ie. obese vs. lean Zucker rats}' one would expect
a concomitant increase in GLUT4 protein concentration. Moreover, there appears
to be little or no correlation between insulin-stimulated 2-deoxyglucose uptake and
total tissue GLUT4 protein content (Brozinick et al. 1993, Henriksen et al. 1992).
In part, this lack of correlation is due to the possible existence of two distinct pools
of GLUT4, one stimulated by insulin and the other stimulated by contraction.
Further, the two pools are fully additive (Brozinick et al. 1993) with respect to 2deoxyglucose transport and together they correlate highly with 2-deoxyglucose uptake
(Henriksen et al. 1992). It has also been demonstrated that this impairment in 2deoxyglucose transport is related to aberrations in GLUT4 protein activation,
translocation and compartmentalization, not total tissue GLUT4 protein content
(Brozinick et al. 1992 and 1993, Friedman et al. 1990, Henriksen et al. 1992).
Consequently, the total tissue concentration of GLUT4 protein may be of limmited
value in predicting transporter capacity.

In fact, activation, translocation and

compartmentalization of GLUT4 is more instrumental in the aberrant transport of
glucose associated with the obese Zucker rat (Brozinick et al. 1992 and 1993,
Friedman et al. 1990, Henriksen et al. 1992).
In summary, we have demonstrated that aortic tissue contains a substantial
concentration of the insulin-stimulated glucose transporter (GLUT4) and exhibits
insulin dependent glucose transport, which appears to be impaired in obese Zucker
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rats. These data support the concept that vascular smooth muscle is an insulin
sensitive tissue which appears to be partially impaired in obese Zucker rats. Further,
this impairment of "classical" insulin action on vascular smooth muscle may result
from a loss of regulation of "non-classical" insulin actions ie. cell
vascular relaxation in the insulin resistant state.

100

ea2+ regulation of

LITERATURE CITED

Abel MA, Zemel MB: Impaired recovery of vascular smooth muscle cell intracellular
2+ following angiotensin II stimulation in streptozotocin-induced diabetic rats.
FASEB J. 7:A747, 1993

ea.

Abel MA, Zemel MB: Impaired recovery of vascular smooth muscle intracellular
calcium following agonist stimulation in insulin resistant (Zucker obese) rats. Am. J.
Hypertens. 6:500-504, 1993
Armstrong RB, Phelps RO: Muscle fiber type of the rat hindlimb. Am. J. Anatomy
171:259-272, 1984
Bader S, Scholz R, Kellerer M, Tippmer S, Rett K, Mathaei S, Freund P and Haring
HU: Normal insulin receptor tyrosine kinase activity and glucose transporter
(GLUT4) levels in skeletal muscle of hyperinsulinaemic hypertensive rats.
Diabetologia 35:712-718, 1992
Barnard RJ, Youngren JF, Kartel H and Martin DA: Effects of streptozotocin
induced diabetes on glucose transport in skeletal muscle. Endocrinology 126: 19211926, 1990
Bray GA: The Zucker-fatty rat: A review. Fed. Proc. 36:148-153, 1977
Brozinick IT, Etgen GJ, Yaspelkis BB, Kang HY and Ivy JL: Effects of exercise
training on muscle GLUT-4 protein content and translocation in obese Zucker rats.
Am J Physiol 265:E419-E427, 1993
Brozinick IT, Etgen GJ, Yaspelkis BB and Ivy JL: Contraction-activated glucose
uptake is normal in insulin-resistant muscle of the obese Zucker rat. J Appl Physiol
73:382-387, 1992
Castillo CE, Katz A, Spencer MK, Yan Z, Nyomba BL: Fasting inhibits insulin
mediated glycolysis and anaplerosis in human skeletal muscle. Am. J. Physiol.
261:E598-E605, 1991
Cooper DR, Foote J, Petch MC and Schofield PM: Chronic effects of glucose on
insulin signaling in A-10 vascular smooth muscle cells. Arch. Biochem. Biophys.
302:490-498, 1993
Cortez MY, Torgan CE, Brozinick IT, Ivy JL: Insulin resistance of obese Zucker rats
exercise trained at two different intensities. Am. J. Physiol. 261:E613-E619, 1991
101

Crettaz M, Prentki M, Zaninetti D and Jeanrenaud B: Insulin resistance in soleus
muscle from obese Zucker rats: Involvement of several defective sites. Biochem J
186:525-534, 1980
Davidson MB: Editorial: Role of glucose transport and GLUT4 transporter protein
in type 2 diabetes mellitus. J Clin Endrocrinol Metab 77:25-26, 1993
DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J: Regulation of
splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man.
Diabetes 32:35-45, 1983
Eriksson J, Koranyi I, Bourey R, et al.: Insulin resistance in type 2 diabetic patients
and their relatives is not associated with a defect in the expression of the insulin
responsive glucose transporter (GLUT4) gene in human skeletal muscle.
Diabetologia 35:143-147, 1991
Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L,
Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. N.
Engl. J. Med. 317:350-357, 1987
Fletcher JR, Haggarty P, Wable KWJ: Horm01;1al studies of the young lean and obese
Zucker rats. Hormone Metabol. Res. 18: 290-295, 1986
Friedman JE, Dohm GL, Leggett-Frazier N, Elton CW, Tapscott EB, Pories WP and
Caro JF: Restoration of insulin responsiveness in skeletal muscle of morbidly obese
patients after weight loss. Effect on muscle glucose transport and glucose transporter
GLUT4. J Qin Invest 89:701705, 1992
Friedman JE, Sherman WM, Reed MJ, Elton CW, and Dohm GL: Exercise training
increases glucose transporter protein GLUT-4. in skeletal muscle of obese Zucker
(fa/fa) rats. FEBS 268:13-16, 1990
Garvey wr, Maianu L, Hancock JA, Golichowski AM and Baron A: Gene
expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity,
IGT, GDM, and NIDDM. . Diabetes 41:465-475, 1992a
Hall JE, Coleman 1N, Mizelle HL: Does chronic hyperinsulinemia cause
hypertension? Am. J. Hypertens. 2: 171-173, 1989
Handberg A, Vaag A, Damsbo P, Beck-Nielsen J and Vinten J: Expression of
insulin regulatable glucose transporters in skeletalmuscle from type 2 diabetic
patients. Diabetologia 33:625-627, 1990
102

Henriksen JE, Bourey RE, Rodnick KJ, Koranyi L, Permutt MA and Holloszy JO:
Glucose transporter protein content and glucose transport capacity in rat skeletal
muscle. Am J Physiol 259:E593-B598, 1990
Ionescu E, Sauter JF: Jeanrenaud B: Abnormal oral glucose tolerance in genetically
obese (fa/fa) rats. Am. J. Physiol. 248: E500-B506, 1985
Ivy JL, Brozinick IT, Torgan CE, Kastello GM: Skeletal muscle glucose transport in
obese Zucker rats after exercise training. J. Appl. Physiol. 66:2635-2641, 1989
Kahn BB, Horton ES and Cushman SW: Mechanisms for enhanced glucose
transport response to insulin in adipose cells from chronically hyperinsulinemic rats:
Increased translocation of glucose transporters from an enlarged intracellular pool.
J Clin Invest 79:854-859, 1987
Karlstad MD, Sayeed MM: Effect of endotoxic shock on kinetics of system A amino
acid transport in rat soleus muscle. Am. J. Physiol. 251:R150-R156, 1986 .
Kasiske BL, Cleary MP, O'Donnell MP: Effects of genetic obesity on renal structure
and function in the Zucker rat. J. Lab. Clin. Med. 106:598-604, 1985
Kim YC, Zemel MB: Insulin increases vascular smooth muscle recovery from
intracellular calcium loads. Hypertension 22:74-77, 1993
Kurtz TW, Morris RC, Pershadsingh HA: The Zucker fatty rat as a genetic model
of obesity and hypertension. Hypertension 13:896-901, 1989
Martin RJ, Gahagan JH: The influence of age and fasting on serum hormones in the
lean and obese Zucker rats. Proc. Soc. Exper. Biol. Med. 154:610-614, 1977
Pedersen 0, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS and Kahn BB:
Evidence against altered expression of GLUTl or GLUT4 in skeletal muscle of
patients with obesity or NIDDM. Diabetes 39:865-870, 1990
Reddy S, Shehin S, Sowers JR, Dardas G, Zemel MB: Aortic 45Ca flux and blood
pressure regulation in streptozotocin-induced diabetic rats. J. Vasc. Med. Biol. 2:4751, 1990
Rocchini AP: Insulin resistance and blood pressure regulation in obese and nonobese
subjects. Hypertension 17:837-842, 1991
Sambrook J, Fritsch BF, Maniatis T: Molecular Cloning: A lab manual 2nd. ed.
pages 18.53 Cold Spring Harbor Laboratory CSH, NY 11724 Press, 1989

103

Shehin SE, Sowers JR, Zemel MB: Impaired vascular smooth muscle 45Ca efflux and
hypertension in Zucker obese rats. J. Vase. Med. Biol. 1(5):278-281, 1989
Sherman WM, Katz AL, Cutler CL, Withers RT, Ivy JL: Glucose transport: locus of
muscle insulin resistance in obese Zucker rats. Am. J. Physiol. 255:E374-E382, 1988
Stem JS, Johnson PR, Batchelor BR: Pancreatic insulin release and peripheral tissue
resistance in Zucker obese rats fed high- and low-carbohydrate diets. Am. J. Physiol.
228:543-548, 1975
Turinsky J: Dynamics of insulin resistance in denervated slow and fast twitch muscles
in vivo. Am. J. Physiol. 252:R531-R537, 1987
Yoshioka S, Nishino H, Shiraki T, Ikeda K, Koike H, Okuno A, Wada M, Fujiwara
T, Horikoshi H: Antihypertensive effects of CS-045 treatment in obese Zucker rats.
Metabolism 92:75-85, 1993
Youn JH, Gulve EA, Holloszy JO: Calcium stimulates glucose transport in skeletal
muscle by a pathway independent of contraction. Am. J. Physiol. 260:C555-C561,
1991
Young DA, Uhl JJ, Cartee GD, Holloszy JO: Activation of glucose transport in
muscle by prolonged exposure to insulin. J. Biol. Chem. 261: 16049-16053, 1986
Zemel MB, Peuler JD, Sowers JR, Simpson L: Hypertension in insulin-resistant
Zucker obese rats is independent of sympathetic neural support. Am. J. Physiol.
262:E368-E371, 1992
Zemel MB, Reddy S, Sowers JR: Insulin attenuation of vasoconstrictor responses to
phenylephrine in Zucker lean and obese rats. Am. J. Hypertens. 4:537-539, 1991
Zemel MB, Sowers JR, Shehin S, Walsh MF, Levy J: Impaired calcium metabolism
associated with hypertension in Zucker obese rats. Metabolism 39:704-708, 1990
Zemel MB, Reddy S, Shehin SE, Lockette W, Sowers JR: Vascular reactivity in
Zucker obese rats: role of insulin resistance. J. Vase. Med. Biol. 2(2):81-85, 1990
Zucker LM, Antoniades HN: Insulin and obesity in the Zucker genetically obese rat
"Fatty". Endocrinology 90: 1320-1330, 1972

104

PART IV.

A NOVEL GENE-DIET-GENDER RELATIONSHIP ASSOCIATED WITH THE

fa ALLELE

ABSTRACT
The purpose of this study was to determine if there is a fa allele effect in lean
heterozygous (BN/fa) rats subjected to a high fat diet. Lean (BN/BN) and lean
(BN/fa) male/female rats were fed 12% or 48% fat diets for 7 weeks. Food intake
and weight change were recorded weekly to obtain an index of energy efficiency.
After seven weeks, direct intra-arterial blood pressure was measured in conscious,
unrestrained animals. Blood and tissue were collected for subsequent analyses.
Plasma insulin, plasma glucose, plasma cholesterol, perirenal and epididymal fat pad
weights, energy efficiency ratio, weight gain and food intake were all significantly
higher in male rats on the 48% fat diet than male rats on the 12% fat diet. Animals
on the 48% fat diet demonstrated higher fat pad weights than animals on the 12%
fat diet (p < 0.00001) and BN/fa animals had heavier fat pads than BN/BN animals
(p <0.0018). Not surprisingly, males had higher perirenal fat pad weights than
females (p < 0.00001).

Paradoxically, the animals on the 48% fat diet had- a

significantly higher (p < 0.009) concentration· of soleus GLUT4 protein than animals
on the 12% fat diet. In summary, we have demonstrated that a high fat diet
exacerbates insulin resistance and the aberrations associated with insulin resistance.
Furthermore, the effects of the high fat diet are amplified in animals carrying one
copy of the fa allele and female animals appeared to be somewhat resistant to this
diet-gene interaction. Additionally, we have demonstrated that a high fat diet
increases the insulin responsive glucose transporter (GLUT4) protein in skeletal
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muscle regardless of genotype or gender. These data support the concept that
syndrome X is predominantly a male syndrome that
modulated by environmental influences.
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is genetically determined and

INTRODUCTION

Hyperinsulinemia, hypertension, dyslipidemia and android obesity are all
considered risk factors for cardiovascular disease. Further, these risk factors have
a tendency to aggregate and this combination has been termed "syndrome X" or "the
deadly quartet" (Barnard et al. 1992, DeFronzo and Ferrannini 1991, Kaplan 1989,
Reaven 1988). Insulin resistance appears to be the key factor that links this
"syndrome X", especially in genetically susceptible persons (DeFronzo and Ferrannini
1991, Reaven 1988). It has been shown that impaired cellular responses to insulin
results in increased vascular smooth . muscle tone, decreased expression and/or
translocation of the insulin-responsive glucose transporter (GLUT4) protein, and
altered transport of glucose in skeletal muscle and- adipose cells (Dohm et al. 1991,
Ivy et al. 1986, Kahn and Pedersen 1993, Sherman et al. 1988, Zemel et al. 1992).
Additionally, it has been demonstrated that manipulating activity and diet can
alleviate or exacerbate some of the symptoms associated with

syndrome

X. For

. example, physical training can improve the impaired cellular responses to insulin in
skeletal muscle and adipose cells associated with

syndrome

X (Douen et al. 1990,

Friedman et al. 1990, Fushiki et al. 1989, Hirshman et al. 1993, Houmard et al. 1991,
Ploug et al. 1990, Rodnick et al. 1990, Talmadge and Silverman 1991, Young et al.
1989).

Physical training has also been shown to induce recruitment and/or

translocation of GLUT4 (Douen et al. 1990, Friedman et al. 1990, Fushiki et al.
1989, Hirshman et al. 1993, Houmard et al. 1991, Young et al. 1989) and alleviate
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the insulin resistance associated with android-shaped obesity (Krotkiewski and
Bjorntorp 1986).
Dietary manipulation also has the potential to modify peripheral insulin
sensitivity and GLUT4 protein functional activity (Kahn and Pedersen 1993, Lillioja
et al. 1987, Penicaud et al. 1991, Saltin and Gollnick 1986). Rats with diet induced
obesity exhibit suppresed GLUT-4 expression in skeletal muscle (Kahn and Pedersen
1993). Manipulating fat, complex carbohydrate, and sucrose in the diet has a
profound effect on peripheral insulin sensitivity (Barnard et al. 1993). Further, rats
fed diets high in saturated fat became more obese, had elevated fasting insulin levels
and exhibited hypertension when compared with control animals and animals on high
polyunsaturated fat diets (Kaufman et al. 1994).
The obese (fa/fa) Zucker rat is a genetic animal model which exhibits many
of the symptoms of syndrome X. Insulin-resistant skeletal muscle is a chronic defect
of the obese Zucker rat (Cortez et al. 1991, Crettaz et al.1980, Czech et al. 1978, Ivy
et al. 1989, Ivy et al. 1986, Sherman et al. 1988). The obese Zucker rat has also been
established as a model of hypertension and insulin resistance. The obese Zucker rat
exhibits obesity and hyperinsulinemia by 4-5 weeks of age (Bray 1977, Fletcher et al.
1986, Ionescu et al. 1985, Kasiske et al. 1985, Martin and Gahagan 1977, Stern et al.
1975, Zucker and Antoniades 1972), and insulin resistance is evident by 11-13 weeks
of age (Ionescu et al. 1985). The aberrations of syndrome X progress in this model
relatively independent of dietary influences (Cleary et al. 1980), although, it has been
demonstrated that specific aberrations can be blunted with exercise (Brozinick et al.
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1993). In contrast, limited evidence suggests that the heterozygous (Fa/fa) lean
Zucker rat may exhibit a gene dosage effect which may be more sensitive to
environmental manipulations (Figlewicz et al. 1985, Phillips and Cleary 1994, York
et al. 1984). Therefore, the heterozygous lean Zucker rat may be a more appropriate
animal model for the study of gene-environment interaction in syndrome X than the
obese Zucker rat.
Unfortunately, distinguishing between genotypes of lean and obese Zucker rats
has not been possible until later in maturation, when phenotypic markers such as
rectal temperature, body weight and fat pad size are discernible. Furthermore,
distinguishing between homozygous (Fa/Fa) and heterozygous (Fa/fa) lean animals
has been dependent on the known breeding history of parent animals, which appears
problematic in regard to controlling for the litter effect (it is impossible to compare
littermates) and the unequivocal identification of pure Fa/Fa and Fa/fa populations
(Truett et al. 1995). Consequently, little research has been done to examine gene
dosage effects of the fa allele.

Nonetheless, a few studies have shown lean

heterozygote animals to be phenotypically intermediate on several physical and
metabolic parameters (Abel et al. 1995, Baskin et al. 1985, Blonz et al. 1985,
Figlewicz et al. 1985, Orosco et al. 1991, Phillips and Cleary 1994, York et al. 1984,
Truett et al. 1995).
However, with the recent discovery of a restriction fragment length
polymorphism (RFLP) corresponding to a cDNA library clone (VC85) in Brown
Norway/Zucker offspring (Smoller et al. 1993), distinguishing between obese (fa/fa),
1 10

lean homozygous (BN/BN) and lean heterozygous (BN/fa) animals is possible. Thus,
it is now possible to determine if fa gene dosage alters the severity and
developmental progress of obesity, insulin resistance, hyperglycemia, dyslipidemia and
hypertension. Accordingly, the focus of this research was to determine if there is a
gene-diet interaction associated with the fa alleie, potentially modulating GLUT4
protein and classical risk factors associated with syndrome X.
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MATERIALS AND METHODS

Breeding and genotyping of animals

In Brown Norway/Zucker offspring, the restriction fragment length
polymorphism corresponding to a cDNA library clone (VC85) (Smoller et al. 1993)
was used to distinguish between lean homozygous (BN/BN) and lean heterozygous
(BN/fa) animals. The animals were bred and genotyped at Pennington Biomedical
Research Center. Tail segments were used for extraction of high molecular weight
DNA utilizing phenol-chloroform (Autoextract Kit, Isogene Biotechnology, Overland
Park, KS). Restriction endonuclease Taq-1 (Boehringer Mannheim, Indianapolis, IN)
was used to digest DNA, followed by electrophoresis through 1% LE agarose gel
(Sigma, St. Louis, MO) in 40 mM tris(hydrox.ymethyl)aminomethane acetate and 1
mM EDTA and transferred to nylon membranes (Hybond N + , Amersham, UK).
Blots were then hybridized with a 2.1 kb subclone VC85 (American Type Culture
Collection 61067), labelled with 32P-alpha-dATP random priming kit (DECAprime,
Ambion, Austin, TX) in 10% dextran sulfate, lM NaCl, 1 % sodium dodecyl sulfate
and 10 µg/ml sheared salmon sperm DNA at 65°C for 16-24 hours (Truett et al.
1995). Subsequently, the animals were weaned, randomized by sex and litter (Table
IV.1), and placed on a standard rodent chow diet (Agway Prolab Rat Mouse
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Hamster 3000, Syracuse, NY) until seven weeks of age. At seven weeks of age the
animals were placed on their respective diets (Table IV.2).
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Housing and care of animals

Lean (BN/BN) and lean (BN/fa) rats were housed in hanging cages and
provided food and water ad libitum. A temperature of 21°C and an artificial 12-h
light-dark cycle were maintained in the animal room. This study was approved by
the Institutional Animal Care and Use Committee of the University of Tennessee.
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Diet

At seven weeks of age, 16 (BN/BN) and 10 (BN/fa) male and 8 (BN/BN) and
1 1 (BN/fa) female rats were randomly (within litter) assigned to a 12% or 48% fat
diet (Table IV.2). Weekly food intake and body weight were recorded for the
duration of the seven week study. Coconut oil replaced com starch in the high fat
diet, and the essential micronutrient content was adjusted to be equivalent on an
energy basis. Over the seven week period animals were allowed free access to their
assigned diet and water. Energy efficiency ratio was calculated as weight gain
divided by energy intake over the seven week feeding period.

Perirenal and

epididymal fat pads were removed and weighed for subsequent analysis.

1 15

Determination of blood pressure .and plasma measures

After approximately seven weeks on the diet treatment each animal (14-15
weeks of age) was anesthetized with sodium pentobarbital and a femoral arterial
catheter was implanted, exteriorized at the nape of the neck and stored in a tissue
culture cap. Approximatily, seventy two hours post-surgery blood pressure was
measured directly (Micromed Inc. Lexington, KY) in the conscious unrestrained
state. The animals were then anesthetized and exsanguinated by cardiac puncture.
Plasma was collected and cholesterol, triglyceride, glucose and insulin concentrations
were determined using the standard cholesterol, triglyceride and glucose methods
(Sigma, St. Louis, ·MO) and insulin via radioimmunoassay (INCSTAR, Stillwater,
MN) method, respectively.
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Determination of GLUT4 Protein

Thoracic aorta, perirenal fat and soleus were removed from all animals,
washed in ice-cold phosphate-buffered saline, minced and dissolved in suspension and
gel loading buffers (Sambrook et al. 1989). Following ten minutes of boiling, the
preparation was sonicated, centrifuged and the supernatant was removed. Proteins
(200 µg) were separated by 10% SDS-PAGE Tris-glycine and electroblotted and/ or
immobilized on PVDF membrane for immunoblot analysis.
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1-Protein A (NEN,

Boston, MA) and anti-rabbit polyclonal antibody to GLUT4 protein (a gift from Dr.
Samuel Cushman, NIDDK, National Institutes of Health, Bethesda, MD) were used
to determine GLUT4 protein concentrations. Blots were exposed to several films for
2-4 days and densitometry was performed to determine relative concentrations of
tissue GLUT4 protein.
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Statistical Considerations

These studies used a randomized design with two treatments (low and high
fat diets) and four levels (male BN/BN, male BN/fa, female BN/BN, and female
BN/fa rats)(Table IV. 1). The analysis of data had to accommodate unbalanced
groups as previously described by Truett et al. (1995). Therefore, the data were
analyzed under a mixed linear model employing the software PROC MIXED of SAS
(Cary, NC). The dependent variables (weight, weight change, fat pads weight,
GLUT4 protein concentrations, food intake, energy efficiency ratio, mean arterial
pressure, plasma glucose, plasma insulin, glucose/insulin ratio, plasma cholesterol,
and plasma triglycerides) were regressed on the independent variables litter (random
factor), diet, sex, genotype and interactions (fixed factors). Type Ill sum of squares
for unbalanced data was used to compute the F statistic for analysis of variance of
the fixed factors. Significance was confirmed at (p < 0.05) and all data are reported
as means .±. standard error.
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RESULTS

The male and female animals responded differently to the high fat diet
(Figure IV.1 ). For example, the female rats did not show a significant difference in
the amount of weight gained between 48% and 12% fat diets. In contrast, the male
rats on the 48% fat diet gained significantly (p < 0.0027) more weight than the male
rats on the 12% fat diet and the male rats gained significantly (p < 0.00001) more
weight than the female rats. Furthermore, there was a trend (p < 0.055) toward
increased weight gain (97.6 ± 5.9 g vs. 107.1 ± 5.9 g) in BN/BN vs. BN/fa animals.
In parallel, food intake (kcal/week) was higher in male rats on the 48% fat diet than
male rats on the 12% fat diet (p < 0.046) and no difference existed in females on the
respective diets. Similarly, the BN/fa rats consumed significantly (p < 0.036) more
food than the BN/BN rats.

Energy efficiency ratio [weight change(g)/food

intake(kcal)] exhibited trends similar to weight change and food intake (Figure IV.2).
Furthermore, energy efficiency ratio was higher in the 48% fat compared to the 12%
fat diet rats (p < 0.026) and this diet effect was only evident in the male animals. In
addition, the male animals had higher energy efficiency ratios than female animals
(p < 0.00001). Figure IV.1 depicts the growth curves of all eight groups over a seven
week period.
Animals on a 48% fat diet demonstrated higher fat pad weights than animals
on a 12% fat diet (p < 0.00001) and BN/fa animals had heavier fat pads than BN/BN
animals (p < 0.0018). Not surprisingly, males had higher perirenal fat pad weights
1 19

than females (p < 0.00001). Moreover, when fat pad weights were adjusted on an
animal weight basis (pads weight(g)/animal weight(g)] these relationships persisted
(Figures IV. 3,N.4 ). There also appeared to be differential distribution of adiposity
in the two fat pads of the male animals. When comparing body fat partitioning
(perirenal/epididymal fat pad ratio) by diet, the 48% fat diet animals put on more
adiposity in the perirenal fat pads. Moreover, the male BN/fa animals on the 48%
fat diet exhibited a significant (p < 0.0 3) diet-genotype interaction, as they had the
greatest change in fat pad weights.
Fasting plasma insulin values exhibited a significant increase in all rats on the
high fat diet (p < 0.05). The males had higher fasting plasma insulin than the female
rats (p < 0.002) and there was a significant (p < 0.04) diet-sex-genotype interaction.
Similarly, fasting plasma glucose was higher in the 48% fat diet (p < 0.02), higher in
males (p < 0.04) and higher in male BN/BN vs. male BN/fa animals (p < 0.026).
Glucose to insulin ratios were compared as indices of insulin sensitivity. This
revealed decreased insulin sensitivity in animals on a 48% fat diet (p <0.00 3) and a
decreased in insulin sensitivity in male vs. female animals (p < 0.004 ). There was also
a significant sex-genotype and diet-sex-genotype interaction (p < 0.0008) regarding
insulin sensitivity, with male BN/fa and female BN/BN rats exhibiting the most
dramatic decline in insulin sensitivity in response to the 48% fat diet.

Not

surprisingly, total cholesterol was significantly (p < 0.0002) higher in male animals
when compared to female animals. Moreover there was a diet-sex interaction
(p < 0.02 3) revealing an increase in total cholesterol of male animals on a 48% fat
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diet, while females demonstrated no diet effects. Plasma triglycerides were not
significantly different among all eight groups. Mean arterial blood pressures were
similar in most groups, with the exception of BN/fa animals on 48% fat diet, which
exhibited the highest mean arterial blood pressures (p < 0.03).
Animals on the 48% fat diet had a significantly higher (p < 0.009)
concentration of soleus GLUT4 protein than animals on the 12% fat diet (Figure
IV.5). Comparisons in aorta and perirenal fat GLUT4 protein concentrations
revealed no significant relationships, although, there was a trend (p < 0.06) toward an
increase in aorta GLUT4 protein of BN/BN animals on a 48% fat diet vs. BN/BN
animals on a 12% fat diet. This trend was not seen in the BN/fa animals on their
respective diets. There was also a trend (p < 0.06) in perirenal fat GLUT4 protein
concentration, which suggested a higher amount of GLUT4 protein in female than
male rats.
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TAm.B W.1: Distribution of Brown NorwayfhM;kcr offspring by diet, sex and genotype.

DIET

SEX

COPIES /a

n

12% fat diet

female

0

4

1

6

0

8

1

5

0

4

1

5

0

8

1

5

male

48% fat diet

female

male

TOTAL

45
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TABLE IV.2: Composition of 12% and 48% fat diets.

Component

12% fat diet1

48% fat diet1

Cornstarch2

35.1 (g/1 00g)

0.0 (g/ 1 OOg)

Coconut oil2

0.0

19.4

Com oil

5.0

6.2

Casein

20.0

24.8

Cellulose

5.0

6.2

Sucrose

29.9

37.2

AIN Mineral mix

3.5

4.3

AIN Vitamin mix

1.0

1.2

D-1-methionine

0.3

0.5

Choline bitartrate

0.2

0.3

Energy

3.86 (kcal/g)

4.80 (kcal/g)

1

12% and 48% of energy derived from fat

2coconut

oil was substituted for cornstarch in the high fat diet.
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TABLB W.3: Measurements of Brown Norway{Zuder offspring fed 12% or 48% fat diets.

GENDER

FEMALE

DIET

12%

48%

12%

48%

N

10

9

13

13

EER

0.030± 0.002 0.030 ± 0.002 0.046 ± 0.0021 0.053 ± 0. 0021,2

PFP % BW

0.90± 0.14

1.33 ± 0.152

0.91± 0.14

1.77 ± 0.131,2

TC (mg/dL)

79.4±4.1

75.5 ±4.3

86.8 ±4.0

98.8 ± 4.01,2

TG (mg/dL)

46.4 ±6.0

48.4 ± 5.8

50.7 ± 5.6

53.7± 5.5

Glucose (mg/dL)

143.9 ± 6.1

161.9 ± 6.32

158.8± 5.8

168.0 ± 5.5

Insulin (ng/mL)

2.43± 1.01

2.43 ± 0.98

4.01 ± 1.1 1

6.70± 0.961,2

MAP (mmHg)3

126±4

128 ± 5

126±4

131 ± 4

HR

365 ± 18

355± 21

366 ± 18

359± 18

1

MALE

signifacant difference versus females (p<O.O:S)

21ipif"ICUt difference versus 12% fat diet (p < 0.0:S)

3.nae sample sizes for mean arterial prcssure were 8, 6, 10, and 8 iapectively.
KBY: N

s

sample me, EER = energy efficiency ratio (weight change (1,)/energy intake (kcal)) O\ICr 7 weeks, PPP % BW

a:

perirenal fat pads expressed as percent body weight, TC = total cholesterol, TO = triglyceride MAP = mean arterial bl�
,
pressure, HR = heart rate
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TABIE IV.4: Measurements of male Brown Norway(z..k.er offspring fed 1 % or 48% fat diets.
2

DIET

12%

GENOTYPE

BN/BN

BN/fa

BN/BN

BN/fa

N

8

8

5

5

EER

0.047 ± 0.002 0.046 ± 0.003 0.053 ± 0.0031 0.053 ± 0.0031

PFP %· BW

0.73± 0.16

1.11 ± 0.22

1.41 ± 0.161

2.12 ± 0.191,2

EFP % BW

1.17 ± 0.13

1.34 ± 0.17

1.66 ± 0.131

2.30 ± 0.15 1,2

TC (mg/dL)

81.8 ± 4.5

91.7 ± 6.3

98.9 ± 4.61

98.8 ± 6.3

TG (mg/dL)

49.0 ± 6.5

52.3 ± 7.7

51.5 ± 6.3

55.8 ± 7.7

Glucose (mg/dL)

149.4± 6.7

168.3 ± 9.5

164.3 ± 7.2

171.8 ± 8.5

Insulin (ng/mL)

5.10 ± 1.19

2.93 ± 1.74

5.65 ± 1.19

7.73 ± 1.271

MAP (mmHg)3

127± 5

125 ± 6

128± 5

134 ± 6

HR

375 ± 19

355 ± 25

366 ± 2 1

352 ± 25

48%

11ipificant difference versus 12% fat diet (p<O.OS)
2sipmcant difference versus BN/BN (p < 0.05)

31'be sample sizes for mean arterial pressure were 8, 6, 10, and 8 rcspcctivcly.
KEY: N ... sample size, EER = energy efficiency ratio (weight change (g)/energy intake (kcal)) over 7 weeks, PFP % BW ...
perircnal fat pads exprcacd as percent body weight, EFP % BW = cpididymal fat pads exprcacd as percent body weight TC
,
=

total cholesterol, TO

=

triglyceride, MAP

=

mean arterial blood pressure, HR
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=

heart rate
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PigUK IV.1 Growth curves of all Brown Norway/Zucker offspring by diet and gender (mean). 1 p<O.OS versus males, 2 p<O.OS
versus 12% fat diet, 3 p<O.OS versus BN/BN
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DISCUSSION

We have demonstrated that a high fat diet exacerbates insulin resistance and
the aberrations associated with insulin resistance. Moreover, many of the deleterious
effects related to high fat feeding are amplified in animals carrying one copy of the
fa allele and female animals appear to be somewhat resistant to these diet and gene

effects. We have also demonstrated that a high fat diet increases the insulin
responsive glucose transporter (GLUT4) protein in skeletal muscle.
There were several genotype effects related to the fa allele (Table IV.4). For
instance, both epididymal and perirenal fat pad weights were significantly higher in

BN/fa animals when compared to BN/BN littermates. BN/fa animals consumed
significantly more food than BN/BN animals and exhibited a trend (p < 0.055) toward
increased weight gain when compared to BN/BN littermates. · On the 48% fat diet

BN/fa animals had higher mean arterial blood pressures than representative BN/BN
animals. Again, many of the genotype effects were blunted or nonexistent when ·
female BN/BN were compared to female BN/fa animals.
As expected, animals on the high fat diet exhibited an exacerbation of
cardiovascular disease risk factors (Table IV.3). Plasma insulin, plasma glucose,
plasma cholesterol, perirenal and epididymal fat pad weights, energy efficiency ratio,
weight gain and food intake were all significantly higher in rats on a 48% fat diet
than rats on a 12% fat diet. Furthermore, male rats exhibited an increase in
cardiovascular disease risk factors relative to female rats. For instance, plasma
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insulin, plasma glucose, plasma cholesteroi perirenal fat pad weight, energy efficiency
ratio, weight gain and food intake were all significantly higher in male rats vs. female
rats.
Additionally, there were several diet-genotype interactions revealing the most
profound risk factor aberrations occurring in the BN/fa males on the high fat diet.
For example, when comparing epididymal fat pads in male animals on 12% vs 48%
fat diets, there was a diet-genotype interaction revealing a fa effect on adiposity
exacerbated by a high fat diet. Similar to human syndrome X, the male animals with
a genetic predisposition (one fa allele) for insulin resistance appear to exhibit an
exaggerated response to a high fat diet with regard to several syndrome X risk
factors.

Moreover, these data support Reaven's (1988) original hypothesis · of

syndrome X, stating insulin resistance observed from person to person is genetically
determined and insulin's action can be modulated by environment. Furthermore,
these data support the speculation of Kaplan (1989) and Bjomtorp (1991) that
androgens appear to be involved in the basic etiology of syndrome X. Android ·
obesity, as indicated by waist/hip circumference ratio, is a risk factor for
cardiovascular disease. The important component of waist/hip ratio appears to be
the mass of visceral fat, relatively independent of total fat mass.

Bjomtorp

(1992,1991 and 1987) postulated that visceral fat mass is probably increased by
multiple endocrine aberrations, with steroid hormones involved in the basic etiology
of these aberrations. In this study both epididymal and perirenal fat pad weights
were significantly higher in BN/fa animals when compared to BN/BN littermates, but
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BN/fa animals only exhibited a trend toward increased weight gain when compared
to BN/BN littermates. In addition, there was a diet-genotype interaction revealing
a fa effect on this visceral adiposity exacerbated by a high fat diet. This suggests that
in BN/fa male rats on high fat diet visceral fat mass increases in greater proportion
then body weight relative to all other groups. Consequently, these data support the
notion that syndrome X develops in individuals who inherited a genetic
predisposition, which is triggered by the combination of androgens and a high fat
diet.
Surprisingly, the soleus of the animals on a high fat diet contained
substantially (p < 0.009) higher concentrations of GLUT4 protein than soleus from
littermates on a low fat diet. In contrast, other researchers (Kahn and Pedersen
1993, Pedersen et al. 1991) have demonstrated that high fat feeding resulted in
suppression of GLUT4 protein and mRNA in rat skeletal muscle and adipose tissue.
Differences between these investigations and results of the present study may be, in
part, due to differences in experimental design. In the previous studies, the high fat
groups consumed 80% of their energy as fat and 15% as protein, while the two
comparison groups consumed 26% of their energy as protein and 12% and 14% of
their energy as fat, respectively. The lack of appropriate dietary controls in these
studies may have confounded the results. For instance, the high fat group had lower
body weights, plasma glucose levels and plasma insulin levels than control rats.
Further, the high fat group exhibited a decrease in expression of the cytoskeletal
protein /J-actin, reflecting one or several dietary inadequacies leading to growth
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failure.

It is likely that animals subjected to an artificially high fat-low

protein/carbohydrate diet may exhibit ketosis and alterations in satiety, thus resulting
in growth failure. In addition, it was not apparent that the high fat diets in these
studies were adequately adjusted for micronutrient content, thus creating the
potential for key nutrient deficiencies.
Insulin stimulates glucose transport by promoting the translocation and/or
activation of GLUT4 transporter proteins. Further, it is believed that following
activation of insulin receptor tyrosine kinase, there is a site-specific phosphorylation
and activation of phosphoserine phosphatase-I, which dephosphorylates the GLUT4
transporter protein leading to it's activation. Insulin also exerts an effect on the
transcription of specific mRNAs (ie. GLUT4 mRNA) (Baulieu and Kelly 1990,
Begum et al. 1993, Quon et al. 1994, Saltiel 1990). Consequently, it has been
demonstrated that plasma insulin is positively correlated with glucose transport and
GLUT4 protein concentrations (Barnard et al. 1990, Kahn et al. 1987). Oearly, in
a ·hyperinsulinemic model of insulin resistance there would be an expected increase
in GLUT4 protein.
There is an accumulating body of evidence suggesting there is no significant
difference of GLUT4 protein content in normal vs insulin resistant states (Bader et
al. 1992, Brozinick et al. 1991 and 1992, Davidson 1993, Eriksson et al. 1991,
Friedman et al� 1992 and 1990, Garvey et al. 1992, Handberg et al. 1990, Pedersen
et al. 1990). Moreover, there appears to be little or no correlation between insulin
stimulated 2-deoxyglucose uptake and tissue GLUT4 protein content (Brozinick et
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al. 1993, Henriksen et al. 1992). In part, this lack of correlation is due to the
existence of two distinct pools of GLUT4, one stimulated by insulin and the other
stimulated by contraction. Further, the two pools are fully additive (Brozinick et al.
1993) with respect to 2-deoxyglucose transport and together they correlate highly with
2-deoxyglucose uptake (Henriksen et al. 1992). It has also been demonstrated that
this impairment in 2-deoxyglucose transport is related to aberrations in GLUT4
protein activation, translocation and compartmentalization, not total tissue GLUT4
protein content (Brozinick et al. 1992 and 1993, Friedman et al. 1990, Henriksen et
al. 1992). Consequently, the total tissue concentration of GLUT4 protein may be of
limited value in predicting transporter capacity. In fact, activation, translocation and
compartmentalization of GLUT4 appears to be more instrumental in the aberrant
transport of glucose associated with insulin resistant states (Brozinick et al. 1992 and
1993, Friedman et al. 1990, Henriksen et al. 1992). Theoretically, a decrease in the
function of GLUT4 protein may elicit an upregulation of the transporter in an
attempt to compensate for the aberrations in GLUT4 activation, translocation and/or
compartmentalization.
In summary, we have demonstrated that a high fat diet exacerbates insulin
resistance and the aberrations associated with insulin resistance. Furthermore, the
effects of the high fat diet are amplified in animals carrying one copy of the fa allele
and female animals appear to be somewhat resistant to this diet-gene interaction.
Additionally, we have demonstrated that a high fat diet increases the insulin
responsive glucose transporter (GLUT4) protein in skeletal muscle regardless of
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genotype or gender. These data support the concept that syndrome X is genetically
determined and modulated by endocrine and environmental influences (ie. androgens
and diet). Future research should focus on the effect of a high fat diet on the
glucose transport system and examine gene-environment interactions in genetic
models of syndrome X.
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PART V.

SUMMARY AND CONCLUSION

The focus of this dissertation research was to: (a) determine whether aortic
tissue exhibits classical insulin-stimulated glucose transport and if so, is this action
impaired in an insulin resistant model; and (b) determine if there is a gene-diet
interaction associated with the fa (fatty) allele, potentially modulating GLUT4
protein and classical risk factors for syndrome X. These studies were intended to
provide insight into the interaction between geneti� and environment and how this
impacts insulin sensitivity in an animal model representative of syndrome X.
Data presented demonstrates that aortic tissue contains a substantial
concentration of the insulin-stimulated glucose transporter (GLUT4) and exhibits
insulin dependent glucose transport.

Further, insulin-stimulated aortic glucose

transport appeared impaired in obese Zucker rats.

These data support our

hypothesis that vascular smooth muscle is an insulin-sensitive tissue which appears
to be partially impaired in obese Zucker rats. Further, we demonstrated that a high
fat diet exacerbates insulin resistance and the aberrations associated with insulin
resistance. Moreover, the effects of the high fat diet are amplified in animals
carrying one copy of the fa allele and female animals seem some what resistant to
this diet-gene interaction. Additionally, we have demonstrated that a high fat diet
increases the insulin responsive glucose transporter (GLUT4) protein in skeletal
muscle regardless of genotype or gender.

Consequently, the total tissue

concentration of GLUT4 protein may be of limited value in predicting transporter
capacity. In fact, activation, translocation and compartmentalization of GLUT4
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appears to be more instrumental in the aberrant transport of glucose associated with
insulin resistant states. These data support the concept that syndrome X is a
multifactorial syndrome that is genetically determined and predominates in males
but, has the potential to be modulated by environmental manipulation. Future
research should focus on elucidating the effect of a high fat diet on the glucose
transport system and examine gene-environment interactions in genetic models of
syndrome X.
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